<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease - Burkhardt, BEU - 2015 | Cochrane Library</title> <meta content="Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease - Burkhardt, BEU - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009515.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease - Burkhardt, BEU - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009515.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009515.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease" name="citation_title"/> <meta content="Barbara EU Burkhardt" name="citation_author"/> <meta content="Kinderspital Zurich" name="citation_author_institution"/> <meta content="barbara.burkhardt@kispi.uzh.ch" name="citation_author_email"/> <meta content="Gerta Rücker" name="citation_author"/> <meta content="Medical Center ‐ University of Freiburg" name="citation_author_institution"/> <meta content="Brigitte Stiller" name="citation_author"/> <meta content="Heart Center, University of Freiburg" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD009515.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/03/25" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009515.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009515.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009515.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Cardiac Output, Low [etiology, mortality, *prevention &amp; control]; Cardiotonic Agents [adverse effects, *therapeutic use]; Dobutamine [therapeutic use]; Heart Defects, Congenital [mortality, *surgery]; Hydrazones [therapeutic use]; Milrinone [adverse effects, *therapeutic use]; Postoperative Complications [mortality, *prevention &amp; control]; Pyridazines [therapeutic use]; Randomized Controlled Trials as Topic; Simendan; Syndrome; Time Factors" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009515.pub2&amp;doi=10.1002/14651858.CD009515.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="wbKFI7vu";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009515\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009515\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009515\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009515\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009515.pub2",title:"Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease",firstPublishedDate:"Mar 25, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Heart Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=wbKFI7vu&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009515.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009515.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009515.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009515.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009515.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009515.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009515.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009515.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009515.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009515.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6088 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009515.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/full#CD009515-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/full#CD009515-sec-0068"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/full#CD009515-sec-0022"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/full#CD009515-sec-0027"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/full#CD009515-sec-0028"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/full#CD009515-sec-0052"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/full#CD009515-sec-0062"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/appendices#CD009515-sec-0073"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/table_n/CD009515StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/table_n/CD009515StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/information#CD009515-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Barbara EU Burkhardt</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/information#CD009515-cr-0003">Gerta Rücker</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009515.pub2/information#CD009515-cr-0004">Brigitte Stiller</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/information/en#CD009515-sec-0080">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 25 March 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009515.pub2">https://doi.org/10.1002/14651858.CD009515.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009515-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009515-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009515-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009515-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009515-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009515-abs-0001" lang="en"> <section id="CD009515-sec-0001"> <h3 class="title" id="CD009515-sec-0001">Background</h3> <p>Children with congenital heart disease often undergo heart surgery at a young age. They are at risk for postoperative low cardiac output syndrome (LCOS) or death. Milrinone may be used to provide inotropic and vasodilatory support during the immediate postoperative period. </p> </section> <section id="CD009515-sec-0002"> <h3 class="title" id="CD009515-sec-0002">Objectives</h3> <p>This review examines the effectiveness of prophylactic postoperative use of milrinone to prevent LCOS or death in children having undergone surgery for congenital heart disease. </p> </section> <section id="CD009515-sec-0003"> <h3 class="title" id="CD009515-sec-0003">Search methods</h3> <p>Electronic and manual literature searches were performed to identify randomised controlled trials. We searched CENTRAL, MEDLINE, EMBASE and Web of Science in February 2014 and conducted a top‐up search in September 2014 as well as clinical trial registries and reference lists of published studies. We did not apply any language restrictions. </p> </section> <section id="CD009515-sec-0004"> <h3 class="title" id="CD009515-sec-0004">Selection criteria</h3> <p>Only randomised controlled trials were selected for analysis. We considered studies with newborn infants, infants, toddlers, and children up to 12 years of age. </p> </section> <section id="CD009515-sec-0005"> <h3 class="title" id="CD009515-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted data according to a pre‐defined protocol. We obtained additional information from all study authors. </p> </section> <section id="CD009515-sec-0006"> <h3 class="title" id="CD009515-sec-0006">Main results</h3> <p>Three of the five included studies compared milrinone versus levosimendan, one study compared milrinone with placebo, and one compared milrinone verus dobutamine, with 101, 242, and 50 participants, respectively. Three trials were at low risk of bias while two were at higher risk of bias. The number and definitions of outcomes were non‐uniform as well. In one study comparing two doses of milrinone and placebo, there was some evidence in an overall comparison of milrinone versus placebo that milrinone lowered risk for LCOS (risk ratio (RR) 0.52, 95% confidence interval (CI) 0.28 to 0.96; 227 participants). The results from two small studies do not provide enough information to determine whether milrinone increases the risk of LCOS when compared to levosimendan (RR 1.22, 95% CI 0.32 to 4.65; 59 participants). Mortality rates in the studies were low, and there was insufficient evidence to draw conclusions on the effect of milrinone compared to placebo or levosimendan or dobutamine regarding mortality, the duration of intensive care stay, hospital stay, mechanical ventilation, or maximum inotrope score (where available). Numbers of patients requiring mechanical cardiac support were also low and did not allow a comparison between studies, and none of the participants of any study received a heart transplantation up to the end of the respective follow‐up period. Time to death within three months was not reported in any of the included studies. A number of adverse events was examined, but differences between the treatment groups could not be proven for hypotension, intraventricular haemorrhage, hypokalaemia, bronchospasm, elevated serum levels of liver enzymes, or a reduced left ventricular ejection fraction &lt; 50% or reduced left ventricular fraction of shortening &lt; 28%. Our analysis did not prove an increased risk of arrhythmias in patients treated prophylactically with milrinone compared with placebo (RR 3.59, 95% CI 0.83 to 15.42; 238 participants), a decreased risk of pleural effusions (RR 1.78, 95% CI 0.92 to 3.42; 231 participants), or a difference in risk of thrombocytopenia on milrinone compared with placebo (RR 0.86, 95% CI 0.39 to 1.88; 238 participants). Comparisons of milrinone with levosimendan or with dobutamine, respectively, did not clarify the risk of arrhythmia and were not possible for pleural effusions or thrombocytopenia. </p> </section> <section id="CD009515-sec-0007"> <h3 class="title" id="CD009515-sec-0007">Authors' conclusions</h3> <p>There is insufficient evidence of the effectiveness of prophylactic milrinone in preventing death or low cardiac output syndrome in children undergoing surgery for congenital heart disease, compared to placebo. So far, no differences have been shown between milrinone and other inodilators, such as levosimendan or dobutamine, in the immediate postoperative period, in reducing the risk of LCOS or death. The existing data on the prophylactic use of milrinone has to be viewed cautiously due to the small number of small trials and their risk of bias. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009515-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009515-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009515-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009515-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009515-abs-0005">Français</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009515-abs-0004" lang="en"> <h3>Milrinone to prevent reduced heart function and death after heart surgery in children</h3> <p>Background: Children who are born with heart defects often undergo heart surgery at a young age. They are at risk for reduced heart function and death after surgery. Milrinone is a medication that may be used in this situation to make the heart stronger and make it easier for the heart to pump blood into the body. </p> <p>Review question: We wanted to examine if the prophylactic use of milrinone prevents reduced heart function or death in babies and children from birth up to 12 years of age having had heart surgery. We planned to consider the number of children who died during the first 30 days after surgery as well as how many days they lived after surgery, followed up for three months. We searched a number of medical literature databases electronically which collect information about planned, ongoing, or finished studies, in order to find trials of this medication published by September 2014. Trials where children had received milrinone and another group of children had received another drug instead after heart surgery were considered. Data were collected by two review authors independently who had to use a pre‐prepared work sheet. </p> <p>Study characteristics: We found five studies, and we asked the study authors for more information. Three studies compared milrinone versus levosimendan, one study compared milrinone versus placebo, and one compared milrinone versus dobutamine. The patients were given the study drugs for 24 to 48 hours and were watched for six to 78 days. A total of 393 participants were included. </p> <p>Quality of evidence: Thus, the data are from a limited number of small trials and therefore must be viewed with caution. In addition, it was not always clear that the patient groups were formed and treated in a way that would make them completely comparable, that patients stayed in the trial for complete assessment, or that all study results were reported conscientiously. </p> <p>Key results: In one study comparing two doses of milrinone and placebo, milrinone was better than placebo to prevent reduced heart function within 36 hours after surgery, but there was not enough information about long‐term heart function beyond the first postoperative days. It was not shown whether milrinone was better than placebo or than any of the other medications to prevent death, or whether the intensive care unit stay or hospital stay or time on mechanical ventilation was shorter if patients received milrinone. Similarly, when examining the studies regarding side effects of milrinone, we could not prove that milrinone caused more heart rhythm disturbances than dobutamine or placebo, or how it affected heart rhythm compared with levosimendan. We could not generate other useful information from comparing the trials regarding other harms which had been previously ascribed to milrinone, such as high heart rate, low blood pressure, bleeding into the brain's ventricular fluid, low potassium level in the blood, narrowing of the airways, low numbers of platelets in the blood, altered liver function tests, or low measurements of heart function by ultrasound. This was in part due to the different trial designs. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009515-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009515-sec-0068">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009515-sec-0110">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009515-sec-0068"></div> <h3 class="title" id="CD009515-sec-0069">Implications for practice</h3> <section id="CD009515-sec-0069"> <p>There is insufficient evidence of the prophylactic effect of milrinone in preventing mortality or low cardiac output syndrome (LCOS) in children undergoing surgery for congenital heart disease. As much as prophylactic milrinone proved to provide a short‐term benefit in the reduction of LCOS in the immediate postoperative period compared to placebo, there might also be harm in terms of increased risk of arrhythmia, which was however not statistically significant. The existing data on the prophylactic use of milrinone has to be viewed cautiously due to the small number of small trials with different dosing regimens of milrinone and the risk of bias in some of these studies. </p> <p>In the absence of a proven mortality benefit and in the absence of proven long‐term beneficial effects of prophylactic milrinone, clinicians must weigh the short‐term reduction of LCOS risk and concomitant reduction of additional pharmacological support against a possible increase in the risk of arrhythmias. </p> </section> <h3 class="title" id="CD009515-sec-0070">Implications for research</h3> <section id="CD009515-sec-0070"> <p>There are a handful of randomised controlled trials addressing the prophylactic use of milrinone in children after congenital heart surgery. Participant numbers are limited, yielding results with low statistical significance. The number of outcomes reported is also variable. </p> <p>Future studies should maintain the high methodological standards of randomised controlled trials, paying attention to the pharmacokinetic properties of milrinone in different age groups, and ideally include larger numbers of participants. This is especially the case when milrinone is not compared with placebo but instead to other inodilator substances. In order to allow comparisons, a standardised definition of LCOS, with criteria as objective as possible, should be adopted in future clinical trials. Even the use of end‐organ related outcomes, especially neuromonitoring, would make studies more relevant. We would also argue that follow‐up periods in future trials should be extended at least until hospital discharge or possibly longer, in order to detect meaningful long‐term outcomes in addition to mortality. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009515-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009515-sec-0022">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009515-sec-0089">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD009515-sec-0022"></div> <p>With the technical and medical advances of the past few decades, approximately 85% of children with congenital heart disease now reach adulthood (<a href="./references#CD009515-bbs2-0034" title="ErmisPR , MoralesDL . The adult Fontan patient: update for 2011. Methodist Debakey Cardiovascular Journal2011;7(2):3‐8. ">Ermis 2011</a>). Part of this improvement is due to the ability to operate on ever younger and smaller children (<a href="./references#CD009515-bbs2-0071" title="WarnesCA , LiberthsonR , DanielsonGK , DoreA , HarrisL , HoffmanJI , et al. Task force 1: the changing profile of congenital heart disease in adult life. Journal of the American College of Cardiology2001;37(5):1170‐5. ">Warnes 2001</a>). Those children suffering from the most severe forms of cardiac malformations need to undergo corrective or palliative surgery in their first year of life. For example, of the 12,495 procedures performed in 10,780 patients of all ages in Europe in 2009 that are registered in the European Association for Cardio‐Thoracic Surgery (EACTS) congenital database, 6717 procedures (53.8%) were done in 5777 (53.6%) neonates and infants (<a href="./references#CD009515-bbs2-0032" title="EACTS Congenital Database [European Association for Cardio‐Thoracic Surgery Congenital Database]. http://www.eactscongenitaldb.org 31.08.2011. ">EACTS 2011</a>). However, this comes at the cost of a high risk of morbidity and mortality in the postoperative period as evidenced by the fact that 77.6% of deaths in the 30 days following surgery involved neonates and infants (333 out of 429 cases) (<a href="./references#CD009515-bbs2-0032" title="EACTS Congenital Database [European Association for Cardio‐Thoracic Surgery Congenital Database]. http://www.eactscongenitaldb.org 31.08.2011. ">EACTS 2011</a>). </p> <section id="CD009515-sec-0023"> <h3 class="title" id="CD009515-sec-0023">Description of the condition</h3> <p>One important condition associated with increased morbidity and mortality is low cardiac output syndrome (LCOS). LCOS is thought to be due to a combination of the underlying heart disease, myocardial ischaemia from aortic cross‐clamping, the residual effects of cardioplegia, and activation of inflammatory pathways from exposure of blood to foreign surfaces during cardiopulmonary bypass (<a href="./references#CD009515-bbs2-0008" title="BaileyJM , HoffmanTM , WesselDL , NelsonDP , AtzAM , ChangAC , et al. A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. Journal of Pharmacokinetics and Pharmacodynamics2004;31(1):43‐59. ">Bailey 2004</a>). It occurs in up to 25% of young children, even if there are no residual cardiac lesions after surgery (<a href="./references#CD009515-bbs2-0008" title="BaileyJM , HoffmanTM , WesselDL , NelsonDP , AtzAM , ChangAC , et al. A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. Journal of Pharmacokinetics and Pharmacodynamics2004;31(1):43‐59. ">Bailey 2004</a>) and typically occurs between six and 18 hours after surgery in a setting of elevated systemic and pulmonary vascular resistances, impaired myocardial function, and arrhythmias. LCOS is detected invasively or by signs of inadequate oxygen delivery to the organ systems, e.g. tachycardia, poor systemic perfusion, decreased urine output, elevated lactate, and reduced mixed venous oxygen saturation (<a href="./references#CD009515-bbs2-0063" title="StockerCF . Recent developments in the perioperative management of the paediatric cardiac patient. Current Opinion in Anaesthesiology2006;19(4):375‐81. ">Stocker 2006</a>). If left untreated, LCOS can lead to cardiac arrest, the need for cardiopulmonary resuscitation or extracorporeal life support (<a href="./references#CD009515-bbs2-0030" title="Delmo WalterEM , Alexi‐MeskishviliV , HueblerM , LoforteA , StillerB , WengY , et al. Extracorporeal membrane oxygenation for intraoperative cardiac support in children with congenital heart disease. Interactive Cardiovascular and Thoracic Surgery2010;10(5):753‐8. ">Delmo Walter 2010</a>), prolonged mechanical ventilation (<a href="./references#CD009515-bbs2-0061" title="ShiS , ZhaoZ , LiuX , ShuQ , TanL , LinR , et al. Perioperative risk factors for prolonged mechanical ventilation following cardiac surgery in neonates and young infants. Chest2008;134(4):768‐74. ">Shi 2008</a>), a prolonged intensive care stay and increased mortality (<a href="./references#CD009515-bbs2-0027" title="BaysalA , SaşmazelA , YıldırımAİ , KoçakT , SunarH , ZeybekR . The effects of thyroid hormones and interleukin‐8 levels on prognosis after congenital heart surgery [Doğuştan kalp cerrahisinde tiroit fonksiyonları ve interlökin‐8 değerlerinin prognoz üzerine etkisi.]. Turk Kardiyoloji Dernegi Arsivi2010;38(8):537‐43. ">Baysal 2010</a>). Therefore, prevention, early detection, and treatment of postoperative LCOS are paramount. </p> <p>Cardiac output is regarded as low when the pumping capacity of the heart is insufficient to provide enough blood flow to satisfy the oxygen demand of the body tissues (<a href="./references#CD009515-bbs2-0063" title="StockerCF . Recent developments in the perioperative management of the paediatric cardiac patient. Current Opinion in Anaesthesiology2006;19(4):375‐81. ">Stocker 2006</a>). In the adult intensive care setting, cardiac output can be measured directly by indicator dilution techniques like thermodilution (<a href="./references#CD009515-bbs2-0046" title="LemsonJ , deBoodeWP , HopmanJC , SinghSK , van derHoevenJG . Validation of transpulmonary thermodilution cardiac output measurement in a pediatric animal model. Pediatric Critical Care Medicine2008;9(3):313‐9. ">Lemson 2008</a>), by Doppler echocardiography (<a href="./references#CD009515-bbs2-0042" title="HuntsmanLL , StewartDK , BarnesSR , FranklinSB , ColocousisJS , HesselEA . Noninvasive Doppler determination of cardiac output in man. Clinical validation. Circulation1983;67(3):593‐602. ">Huntsman 1983</a>), or by arterial pulse contour analysis (<a href="./references#CD009515-bbs2-0044" title="KimJ , DreyerJ , ChangA . Arterial pulse wave analysis: an accurate means of determining cardiac output in children. Pediatric Critical Care Medicine2006;7:532–5. ">Kim 2006</a>; <a href="./references#CD009515-bbs2-0067" title="TibbySM , MurdochIA . Measurement of cardiac output and tissue perfusion. Current Opinion in Pediatrics2002;14:303–9. ">Tibby 2002</a>). A cardiac index of &lt; 2.2 L/min/m<sup>2</sup> is considered low (<a href="./references#CD009515-bbs2-0041" title="HochmanJS , SleeperLA , WebbJG , SanbornTA , WhiteHD , TalleyJD , et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. New England Journal of Medicine1999;341(9):625‐34. ">Hochman 1999</a>; <a href="./references#CD009515-bbs2-0056" title="RaoV , IvanovJ , WeiselRD , IkonomidisJS , ChristakisGT , DavidTE . Predictors of low cardiac output syndrome after coronary artery bypass. Journal of Thoracic and Cardiovascular Surgery1996;112(1):38‐51. ">Rao 1996</a>). In children, especially in neonates and infants, it is usually not feasible to employ these techniques due to device sizes, shunts, and other characteristics of cardiovascular physiology (<a href="./references#CD009515-bbs2-0066" title="TengS , KaufmanJ , PanZ , CzajaA , ShockleyH , daCruzE . Continuous arterial pressure waveform monitoring in pediatric cardiac transplant, cardiomyopathy and pulmonary hypertension patients. Intensive Care Medicine2011;37(8):1297‐301. ">Teng 2011</a>), as well as poor correlation with tissue oxygen delivery (<a href="./references#CD009515-bbs2-0028" title="BohnD . Objective assessment of cardiac output in infants after cardiac surgery. Seminars in Thoracic and Cardiovascular Surgery: Pediatric Cardiac Surgery Annual2011;14(1):19‐23. ">Bohn 2011</a>). With lack of a clear definition, different authors describe various parameters, which are often used as a compound measure. Such a composite parameter for LCOS may consist of several of the following findings: </p> <p> <ul id="CD009515-list-0001"> <li> <p>elevated blood lactate or rapid increase in blood lactate (<a href="./references#CD009515-bbs2-0029" title="CharpieJR , DekeonMK , GoldbergCS , MoscaRS , BoveEL , KulikTJ . Serial blood lactate measurements predict early outcome after neonatal repair or palliation for complex congenital heart disease. Journal of Thoracic and Cardiovascular Surgery2000;120(1):73‐80. ">Charpie 2000</a>), </p> </li> <li> <p>decreased central venous oxygen saturation (<a href="./references#CD009515-bbs2-0063" title="StockerCF . Recent developments in the perioperative management of the paediatric cardiac patient. Current Opinion in Anaesthesiology2006;19(4):375‐81. ">Stocker 2006</a>), </p> </li> <li> <p>increase in arterial to central venous oxygen saturation difference,</p> </li> <li> <p>decreased urine output (<a href="./references#CD009515-bbs2-0063" title="StockerCF . Recent developments in the perioperative management of the paediatric cardiac patient. Current Opinion in Anaesthesiology2006;19(4):375‐81. ">Stocker 2006</a>), </p> </li> <li> <p>increased peripheral skin temperature to core body temperature difference,</p> </li> <li> <p>echocardiographic Doppler‐derived low cardiac index</p> </li> <li> <p>high inotrope requirement (<a href="./references#CD009515-bbs2-0062" title="ShoreS , NelsonDP , PearlJM , ManningPB , WongH , ShanleyTP , et al. Usefulness of corticosteroid therapy in decreasing epinephrine requirements in critically ill infants with congenital heart disease. American Journal of Cardiology2001;88(5):591‐4. ">Shore 2001</a>). </p> </li> </ul> </p> <p>The mainstays of treatment include catecholamines, calcium sensitisers, and phosphodiesterase inhibitors (usually milrinone) (<a href="./references#CD009515-bbs2-0063" title="StockerCF . Recent developments in the perioperative management of the paediatric cardiac patient. Current Opinion in Anaesthesiology2006;19(4):375‐81. ">Stocker 2006</a>). A recent survey of hospitals in 31 European countries showed that treatment regimens are highly variable between centres, which was attributed to the lack of licensing and dosing guidance in many instances. It also showed that milrinone is being favoured in LCOS with elevated systemic vascular resistance and is also used in LCOS with elevated pulmonary vascular resistance (<a href="./references#CD009515-bbs2-0069" title="VogtW , LäerS . Treatment for paediatric low cardiac output syndrome: results from the European EuLoCOS‐Paed survey. Archives of Disease in Childhood2011;96(12):1180‐6. ">Vogt 2011a</a>). </p> </section> <section id="CD009515-sec-0024"> <h3 class="title" id="CD009515-sec-0024">Description of the intervention</h3> <p>In the adult population, phosphodiesterase type III inhibitors have been used extensively for congestive heart failure in the past and in the postoperative management of patients undergoing coronary artery bypass grafting (<a href="./references#CD009515-bbs2-0035" title="FeneckRO . Intravenous milrinone following cardiac surgery: I. Effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group. Journal of Cardiothoracic and Vascular Anesthesia1992;6(5):554‐62. ">Feneck 1992</a>). The use of milrinone in adult acute heart failure has however diminished, supported by ADHERE registry data, which showed that patients treated with milrinone were among those with a higher mortality (<a href="./references#CD009515-bbs2-0021" title="AbrahamWT , AdamsKF , FonarowGC , CostanzoMR , BerkowitzRL , LeJemtelTH , et al. In‐hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). Journal of the American College of Cardiology2005;46(1):57‐64. ">Abraham 2005</a>) compared to those receiving other medications. The drug did not play a large role in more recent surveys on heart failure treatment such as EuroHeart Failure Survey II (<a href="./references#CD009515-bbs2-0051" title="NieminenMS , BrutsaertD , DicksteinK , DrexlerH , FollathF , HarjolaVP , et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. European Heart Journal2006;27(22):2725‐36. ">Nieminen 2006</a>), ALARM‐HF (<a href="./references#CD009515-bbs2-0037" title="FollathF , YilmazMB , DelgadoJF , ParissisJT , PorcherR , GayatE , et al. Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM‐HF). Intensive Care Medicine2011;37(4):619‐26. ">Follath 2011</a>), and the Get With The Guidelines‐Heart Failure registry (<a href="./references#CD009515-bbs2-0022" title="AllenLA , FonarowGC , Grau‐SepulvedaMV , HernandezAF , PetersonPN , PartovianC , et al. Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from Get With The Guidelines. Circulation Heart Failure2014;7(2):251‐60. ">Allen 2014</a>). In contrast, children with acute heart failure from cardiomyopathy receive milrinone more commonly (<a href="./references#CD009515-bbs2-0049" title="MoffettBS , PriceJF . National prescribing trends for heart failure medications in children. Congenital Heart Disease2015;10(1):78‐85. [DOI: 10.1111/chd.12183] ">Moffett 2015</a>). </p> <p>In children undergoing congenital heart surgery, milrinone is thought to decrease the incidence of low cardiac output syndrome without an increase in adverse reactions (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>). Adverse effects have been described in terms of arrhythmias (<a href="./references#CD009515-bbs2-0036" title="FlemingGA , MurrayKT , YuC , ByrneJG , GreelishJP , PetracekMR , et al. Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery. Circulation2008;118(16):1619‐25. ">Fleming 2008</a>), hypotension (<a href="./references#CD009515-bbs2-0043" title="JeonY , RyuJH , LimYJ , KimCS , BahkJH , YoonSZ , et al. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone‐induced hypotension in off‐pump coronary artery bypass surgical patients. European Journal of Cardiothoracic Surgery2006;29(6):952‐6. ">Jeon 2006</a>), tachycardia (<a href="./references#CD009515-bbs2-0052" title="ParadisisM , EvansN , KluckowM , OsbornD . Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants. Journal of Pediatrics2009;154(2):189‐95. ">Paradisis 2009</a>), hypokalaemia, bronchospasm, headaches, thrombocytopenia (<a href="./references#CD009515-bbs2-0055" title="RamamoorthyC , AndersonGD , WilliamsGD , LynnAM . Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery. Anesthesia and Analgesia1998;86(2):283‐9. ">Ramamoorthy 1998</a>), anaemia, and elevated serum levels of liver enzymes (<a href="./references#CD009515-bbs2-0058" title="SanofiAventis . Drug reference Corotrop® (Milrinone) [Fachinformation Corotrop®]. Rote Liste® Service GmbH •  Mainzer Landstr. 55 • 60329 Frankfurt/MainAugust 2010. ">Sanofi Aventis 2010</a>). In neonates treated with milrinone, intraventricular haemorrhage has been observed as well (<a href="./references#CD009515-bbs2-0026" title="BasslerD , ChoongK , McNamaraP , KirpalaniH . Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biology of the Neonate2006;89(1):1‐5. ">Bassler 2006</a>). Milrinone as a prophylactic medication is administered intravenously, either as a bolus, or as a loading dose followed by continuous infusion, or by continuous infusion only. In clinical trials, doses have been chosen as follows: bolus doses given as 50 μg/kg of body weight (<a href="./references#CD009515-bbs2-0025" title="BaileyJM , MillerBE , LuW , TosoneSR , KanterKR , TamVK . The pharmacokinetics of milrinone in pediatric patients after cardiac surgery. Anesthesiology1999;90(4):1012‐8. ">Bailey 1999</a>). Typical loading doses ranged from 25 μg/kg intravenously (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>) to 250 μg/kg of body weight administered into the cardiopulmonary bypass priming volume (<a href="./references#CD009515-bbs2-0019" title="ZuppaAF , NicolsonSC , AdamsonPC , WernovskyG , MondickJT , BurnhamN , et al. Population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing stage I reconstruction. Anesthesia and Analgesia2006;102(4):1062‐9. ">Zuppa 2006</a>). Continuous infusion rates varied between 0.2 μg/kg/min (<a href="./references#CD009515-bbs2-0019" title="ZuppaAF , NicolsonSC , AdamsonPC , WernovskyG , MondickJT , BurnhamN , et al. Population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing stage I reconstruction. Anesthesia and Analgesia2006;102(4):1062‐9. ">Zuppa 2006</a>) and 0.75 μg/kg/min (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>). The medication is started immediately or within several hours after separation from cardiopulmonary bypass, when surgical correction or palliation of the heart defect is completed. Usual infusion periods for continuous administration were up to 36 hours (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>) or even several days. In clinical practice, milrinone is reported to be used either alone or in combination with other medications, at bolus doses of 50 to 300 μg/kg, followed by maintenance infusion rates of 0.2 to 1.5 μg/kg, with higher variability in combination regimens than with milrinone as a monotherapy (<a href="./references#CD009515-bbs2-0069" title="VogtW , LäerS . Treatment for paediatric low cardiac output syndrome: results from the European EuLoCOS‐Paed survey. Archives of Disease in Childhood2011;96(12):1180‐6. ">Vogt 2011a</a>; <a href="./references#CD009515-bbs2-0070" title="VogtW , LäerS . Prevention for pediatric low cardiac output syndrome: results from the European survey EuLoCOS‐Paed. Paediatric Anaesthesia2011;21(12):1176‐84. ">Vogt 2011b</a>). </p> </section> <section id="CD009515-sec-0025"> <h3 class="title" id="CD009515-sec-0025">How the intervention might work</h3> <p>Milrinone is a phosphodiesterase type III inhibitor, exerting its pharmacologic action by increasing the intracellular cAMP concentration, which in turn has inotropic and lusitropic effects relating to intracellular calcium handling in cardiac myocytes (<a href="./references#CD009515-bbs2-0033" title="elAllafD , D'OrioV , CarlierJ . The new inotropic phosphodiesterase inhibitors. Archives of Physiology and Biochemistry1984;92(4):S69‐79. ">el Allaf 1984</a>). In the peripheral and pulmonary vasculature, phosphodiesterase type III inhibitors act as vasodilators, thereby decreasing systemic and pulmonary vascular resistance (<a href="./references#CD009515-bbs2-0023" title="AlousiAA , JohnsonDC . Pharmacology of the bipyridines: amrinone and milrinone. Circulation1986;73(3 Pt 2):III10‐24. ">Alousi 1986</a>; <a href="./references#CD009515-bbs2-0064" title="StockerCF , ShekerdemianLS , NørgaardMA , BrizardCP , MynardJP , HortonSB , et al. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass. Critical Care Medicine2007;35(1):252‐9. ">Stocker 2007</a>). </p> </section> <section id="CD009515-sec-0026"> <h3 class="title" id="CD009515-sec-0026">Why it is important to do this review</h3> <p>In the paediatric age group, a large percentage of drugs are used off‐label, that is in ways that are not formally approved, depending largely on information from adult trials. In cardiovascular medicine especially, there is a great discrepancy between the availability of trial information from many large adult studies and systematic reviews/meta‐analyses, and very little knowledge about drug effects in children (<a href="./references#CD009515-bbs2-0053" title="PasqualiSK , HallM , SlonimAD , JenkinsKJ , MarinoBS , CohenMS , et al. Off‐label use of cardiovascular medications in children hospitalized with congenital and acquired heart disease. Circulation: Cardiovascular Quality and Outcomes2008;1(2):74‐83. ">Pasquali 2008</a>). This is even more striking as cardiac defects constitute the most common type of separate congenital organ malformations, affecting between 0.72% (<a href="./references#CD009515-bbs2-0031" title="DilberD , MalcićI . Spectrum of congenital heart defects in Croatia. European Journal of Pediatrics2010 May;169(5):543‐50. ">Dilber 2010</a>) and 1.08% of newborns (<a href="./references#CD009515-bbs2-0047" title="LindingerA , SchwedlerG , HenseHW . Prevalence of congenital heart defects in newborns in Germany: Results of the first registration year of the PAN Study (July 2006 to June 2007) [Prävalenz angeborener Herzfehler bei Neugeborenen in Deutschland: Ergebnisse des ersten Geburtsjahrganges (Juli 2006 bis Juni 2007)]. Klinische Pädiatrie2010;222(5):321‐6. ">Lindinger 2010</a>). </p> <p>The most common indication for milrinone in the paediatric age group is in children with congenital heart defects undergoing palliative or corrective surgery, in order to prevent or treat low cardiac output syndrome after cardiopulmonary bypass. As of July 6, 2011, the European Medicines Agency has issued a Public Assessment Report (in accordance with article 45 of the Paediatric regulation) of milrinone, indicating the use of this substance for “the short‐term treatment (up to 35 hours) for severe congestive heart failure unresponsive to conventional maintenance therapy, and for the short‐term treatment (up to 35 hours) of paediatric patients with acute heart failure, including low output states following cardiac surgery” (<a href="./references#CD009515-bbs2-0024" title="Anonymous . Heads of Medicines Agencies EU worksharing procedure for assessment of paediatric data for milrinone. http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Paediatric_Regulation/Assessment_Reports/Article_45_work‐sharing/Milrinone‐_2011_06_Art.45PaedPdAR.pdf 06/07/2011. ">Anonymous 2011</a>). Prophylactic use has not been approved by the European Medicines Agency. </p> <p>However, the EuLoCOS survey of hospitals in Europe showed that preventive drug administration in patients at risk for LCOS is common, and that milrinone is the most widely preferred drug, either alone or in combination with other drugs, in varying doses and modes of administration (<a href="./references#CD009515-bbs2-0070" title="VogtW , LäerS . Prevention for pediatric low cardiac output syndrome: results from the European survey EuLoCOS‐Paed. Paediatric Anaesthesia2011;21(12):1176‐84. ">Vogt 2011b</a>). The frequent use of milrinone warrants further investigation into its effects in children undergoing surgery for congenital heart disease, especially if used prophylactically, in order to allow evidence‐based decisions. </p> <p>This review is an essential step to permit further relevant and ethical clinical trials in the paediatric population as needed, or to possibly prevent more children from being subjected to unnecessary trials, depending on its outcome. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009515-sec-0027" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009515-sec-0027">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009515-sec-0094">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009515-sec-0027"></div> <p>This review examines the effectiveness of prophylactic postoperative use of milrinone to prevent LCOS or death in children having undergone surgery for congenital heart disease. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009515-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009515-sec-0028">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009515-sec-0095">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009515-sec-0028"></div> <section id="CD009515-sec-0029"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009515-sec-0030"> <h4 class="title">Types of studies</h4> <p>Only randomised controlled trials were considered.</p> </section> <section id="CD009515-sec-0031"> <h4 class="title">Types of participants</h4> <p>Newborns, infants, toddlers, and children from birth to 12 years of age undergoing corrective or palliative heart surgery for congenital heart disease. </p> </section> <section id="CD009515-sec-0032"> <h4 class="title">Types of interventions</h4> <p>Intervention: Prophylactic milrinone intravenous infusion alone or combined with other inotrope medications and/or vasopressin and/or calcium sensitisers and/or nitric oxide, started within six hours of surgery for congenital heart disease and irrespective of the administration protocol, provided that milrinone bolus doses, if any, are at least 25 μg/kg and continuous infusion rates are at least 0.2 μg/kg/min, and that milrinone is administered for a duration of at least four hours. </p> <p>Comparative intervention: No milrinone infusion and a) or b):</p> <p>(a) Placebo: Depending on the surgical intervention, children will rarely be weaned from cardiopulmonary bypass without inotropic medications. If any trials exist comparing milrinone with placebo, these will be included in future updates of this review. </p> <p>(b) Other inotrope medications and/or vasopressin and/or calcium sensitisers and/or nitric oxide/nitroprusside alone. Inotropes (usually catecholamines) such as epinephrine, norepinephrine, dopamine, or dobutamine, may be used in combination with vasopressin and/or with calcium sensitisers such as levosimendan and/or combined with inhaled nitric oxide/ intravenous nitroprusside. </p> <p>These combination regimens were regarded as eligible comparators, as long as they did not contain milrinone. Studies using medication regimens that contain other phosphodiesterase type III inhibitors (amrinone, inamrinone, enoximone, piroximone, pimobendane, imazodan, sulmazole, isomazole, flosequinan, indolidan, carbazeran, quazinone, adibendan, pelrinone, olprinone, siguazodan, cilostamide, cilostazol, zardaverine, alifedrine, lixazinone) were also excluded. </p> </section> <section id="CD009515-sec-0033"> <h4 class="title">Types of outcome measures</h4> <section id="CD009515-sec-0034"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD009515-list-0002"> <li> <p>Total mortality within 30 days</p> </li> <li> <p>Time to death (censored after three months)</p> </li> <li> <p>Low cardiac output syndrome as defined by authors of individual studies and typically based on two or more of the following: </p> </li> </ol> <ul id="CD009515-list-0003"> <li> <p>blood lactate &gt; 3 mmol/L (27 mg/dL) or increase in blood lactate of at least 2 mmol/L (18 mg/dL) from baseline, </p> </li> <li> <p>central venous oxygen saturation &lt; 50% in biventricular physiology without shunts,</p> </li> <li> <p>increase in arterial to central venous oxygen saturation difference by at least 20% from baseline, </p> </li> <li> <p>urine output &lt; 1 mL/kg/hour,</p> </li> <li> <p>peripheral skin temperature to core body temperature difference of &gt; 7°C,</p> </li> <li> <p>cardiac index as determined by Doppler echocardiography of &lt; 2.2 L/min/m<sup>2</sup> </p> </li> </ul> </p> </section> <section id="CD009515-sec-0035"> <h5 class="title">Secondary outcomes</h5> <p>Duration of intensive care stay, duration of hospital stay, duration of mechanical ventilation, inotrope score, number of patients requiring mechanical circulatory support (e.g. ECMO, pulsatile assist devices) or cardiac transplantation. </p> <section id="CD009515-sec-0036"> <h6 class="title">Safety outcomes</h6> <p>Number/proportion of adverse events. Adverse events include:</p> <p> <ul id="CD009515-list-0004"> <li> <p>arrhythmias (number/proportion),</p> </li> <li> <p>tachycardia (number/proportion of patients with heart rate above heart rate appropriate for age or body surface area), </p> </li> <li> <p>hypotension (number/proportion of patients with blood pressures below blood pressure appropriate for age or body surface area), </p> </li> <li> <p>intraventricular haemorrhage (number/proportion),</p> </li> <li> <p>hypokalaemia (number/proportion),</p> </li> <li> <p>bronchospasm (number/proportion),</p> </li> <li> <p>thrombocytopenia (number/proportion of patients with platelet count &lt; 50,000/mm<sup>3</sup> or with a drop in platelet count of &gt;100% from baseline prior to administration of milrinone), </p> </li> <li> <p>elevated serum levels of liver enzymes (number/proportion of patients with serum enzymatic activities more than two‐fold the age‐appropriate normal values), </p> </li> <li> <p>left ventricular ejection fraction &lt; 50% or left ventricular fraction of shortening &lt; 28% as assessed by biplane or M‐mode echocardiography. </p> </li> </ul> </p> </section> </section> </section> </section> <section id="CD009515-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009515-sec-0038"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL, 2014, Issue 1 of 12) in <i>The Cochrane Library</i>, MEDLINE (OVID, 1946 to January Week 4 2014), EMBASE (OVID, 1980 to 2014 Week 04), and Web of Science (Thomson Reuters, 1970 to 31 January 2014) on 5 February 2014. No language restrictions were applied. </p> <p>We performed an additional search in September 2014. The results of this search have been screened but have not yet been fully incorporated in this review (see <a href="./references#CD009515-sec-0088" title="">Characteristics of studies awaiting classification</a>). </p> <p>Clinical trial registries were consulted for trials that were completed or nearing completion but had not been published yet. Specifically, the following registries were searched: </p> <p> <ul id="CD009515-list-0005"> <li> <p>Clinicaltrials (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>), searched on 29 February 2012 (search term “milrinone”). </p> </li> <li> <p>EU Clinical Trials Register, EU‐CTR Version: 1.1.2 (<a href="https://www.clinicaltrialsregister.eu/ctr-search/search?query=milrinone" target="_blank">https://www.clinicaltrialsregister.eu/ctr‐search/search?query=milrinone</a>), searched on 17 August 2012 (search term “milrinone”). </p> </li> <li> <p>IFPMA (International Federation of Pharmaceutical Manufacturers &amp; Associations) Clinical Trials Portal (<a href="http://clinicaltrials.ifpma.org/clinicaltrials/no_cache/de/suche/index.htm" target="_blank">http://clinicaltrials.ifpma.org/clinicaltrials/no_cache/de/suche/index.htm</a>) searched on 17 August 2012 (search term “milrinone”). </p> </li> <li> <p>metaRegister of current controlled trials (<a href="http://www.controlled-trials.com/mrct/search.html" target="_blank">http://www.controlled‐trials.com/mrct/search.html</a>), searched on 29 February 2012 (search terms “milrinone AND surgery”). </p> </li> <li> <p>WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">http://apps.who.int/trialsearch/</a>), searched on 29 February 2012 (search term “milrinone”). </p> </li> <li> <p>Forschungsdatenbank Universität Zürich (<a href="http://www.research-projects.uzh.ch/info/index.html" target="_blank">http://www.research‐projects.uzh.ch/info/index.html</a>), searched on 29 February 2012 (search term “milrinone”). </p> </li> </ul> </p> <p>The Cochrane sensitivity‐maximising RCT filter (<a href="./references#CD009515-bbs2-0045" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Lefebvre, 2011</a>) has been used for MEDLINE and adaptations of it for the other databases except CENTRAL. The search strategies can be found in <a href="./appendices#CD009515-sec-0074">Appendix 1</a>. </p> </section> <section id="CD009515-sec-0039"> <h4 class="title">Searching other resources</h4> <p>We handsearched reference lists of published studies for further trials. Also, we scanned general reviews and overviews for relevant citations. We asked the manufacturer (Sanofi Aventis) to provide us with information about any additional trials. We contacted authors of published trials and expert colleagues from scientific medical societies (Association for European Paediatric Cardiology, American Academy of Pediatrics Section on Cardiology and Cardiac Surgery, American Heart Association Council on Cardiovascular Disease in the Young (Congenital Cardiac Defects Committee), and Japanese Society of Pediatric Cardiology and Cardiac Surgery) to find out about possible unpublished data. The German society for Pediatric Cardiology (Deutsche Gesellschaft für Pädiatrische Kardiologie) was not contacted separately, since BS is the 2014 president of the society. </p> </section> </section> <section id="CD009515-sec-0040"> <h3 class="title" id="CD009515-sec-0040">Data collection and analysis</h3> <p>We carried out data analysis out using RevMan 5.2 software. Additionally, we performed some analyses using R package `meta' (<a href="./references#CD009515-bbs2-0054" title="R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna 2013. Vienna: R Foundation, 2013. ">R 2013</a>; <a href="./references#CD009515-bbs2-0059" title="SchwarzerG . meta: An R package for Meta‐Analysis. R News2007;7(3):40‐5. ">Schwarzer 2007</a>). </p> <section id="CD009515-sec-0041"> <h4 class="title">Selection of studies</h4> <p>Two review authors (BB, BS) independently selected records for full‐text review. if there were any disagreements, we considered the full texts.. Again, the same two review authors examined the full texts for inclusion and arrived at the same selection of studies. We only selected randomised controlled trials for analysis. We documented study selection according to the PRISMA statement format (<a href="./references#CD009515-bbs2-0050" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. BMJ2009;339:b2535. ">Moher 2009</a>). </p> </section> <section id="CD009515-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (BB and BS) independently extracted data according to a pre‐defined protocol and using the same data extraction work sheet (<a href="#CD009515-tbl-0001">Table 1</a>). We settled any differences by discussion with the third author (GR). Whenever quality assessment of data revealed shortcomings of the publications identified, for example, lack of information of methods used for allocation concealment in randomised trials, we contacted trial authors and asked them to provide further information in order to obtain as complete a data set as possible concerning each individual study. </p> <div class="table" id="CD009515-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Data extraction form</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Questions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Answers</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AUTHORS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PUBLICATION ID</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PUBLICATION SOURCE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>STUDY DESIGN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DATES OF STUDY</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LOCATION</p> <p>and number of centres</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SETTING</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SEQUENCE GENERATION</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ALLOCATION SEQUENCE CONCEALMENT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>BLINDING</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OTHER CONCERNS ABOUT BIAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PARTICIPANTS</p> <p>Number screened</p> <p>Number randomised</p> <p>Number completed</p> <p>Number of male/female participants</p> <p>Participant ages</p> <p>Inclusion criteria</p> <p>Exclusion criteria</p> <p>Co‐morbidity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>INTERVENTIONS</p> <p>Total number of intervention groups</p> <p>Number of patients in each group</p> <p>Specific interventions: drugs</p> <p>Intervention details (bolus and infusion or infusion only, infusion rate, starting time of infusion after surgery, duration of infusion) </p> <p>Co‐interventions</p> <p>Follow‐up period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OUTCOMES</p> <p>Outcomes reported</p> <p>Subgroup analyses (infants/children, univentricular/biventricular)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RESULTS</p> <p>MORTALITY WITHIN 30 DAYS</p> <p>Sample size</p> <p>Number of missing participants</p> <p>Summary data for each intervention group</p> <p>Estimate of effect with confidence interval; P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TIME TO DEATH (CENSORED AFTER 3 MONTHS)</p> <p>Sample size</p> <p>Number of missing participants</p> <p>Summary data for each intervention group</p> <p>Estimate of effect with confidence interval; P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LCOS WITHIN 30 DAYS FROM SURGERY</p> <p>Sample size</p> <p>Number of missing participants</p> <p>LCOS definition (with diagnostic criteria)</p> <p>Summary data for each intervention group</p> <p>Estimate of effect with confidence interval; P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DURATION OF ICU STAY</p> <p>Sample size</p> <p>Number of missing participants</p> <p>Summary data for each intervention group</p> <p>Estimate of effect with confidence interval; P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DURATION OF HOSPITAL STAY</p> <p>Sample size</p> <p>Number of missing participants</p> <p>Summary data for each intervention group</p> <p>Estimate of effect with confidence interval; P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DURATION OF MECHANICAL VENTILATION</p> <p>Sample size</p> <p>Number of missing participants</p> <p>Summary data for each intervention group</p> <p>Estimate of effect with confidence interval; P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MAXIMUM INOTROPE SCORE</p> <p>Sample size</p> <p>Number of missing participants</p> <p>Summary data for each intervention group</p> <p>Estimate of effect with confidence interval; P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NUMBER OF PATIENTS REQUIRING MECHANICAL CIRCULATORY SUPPORT WITHIN 30 DAYS FROM SURGERY</p> <p>Sample size</p> <p>Number of missing participants</p> <p>Summary data for each intervention group</p> <p>Estimate of effect with confidence interval; P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NUMBER OF PATIENTS REQUIRING HEART TRANSPLANT WITHIN 30 DAYS FROM SURGERY</p> <p>Sample size</p> <p>Number of missing participants</p> <p>Summary data for each intervention group</p> <p>Estimate of effect with confidence interval; P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NUMBER/PROPORTION OF ADVERSE EVENTS</p> <p>arrhythmias</p> <p>tachycardia</p> <p>hypotension</p> <p>intraventricular haemorrhage</p> <p>hypokalaemia</p> <p>bronchospasm</p> <p>thrombocytopenia</p> <p>elevated serum levels of liver enzymes</p> <p>left ventricular ejection fraction &lt;50% or left ventricular fraction of shortening &lt; 28% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FUNDING SOURCE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>INTENTION‐TO‐TREAT ANALYSIS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>KEY CONCLUSIONS OF THE STUDY AUTHORS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MISCELLANEOUS COMMENTS FROM THE STUDY AUTHORS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>REFERENCES TO OTHER RELEVANT STUDIES</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CORRESPONDENCE REQUIRED?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes/No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MISCELLANEOUS COMMENTS FROM THE REVIEW AUTHORS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RISK OF BIAS</p> <p>Random sequence generation</p> <p>Allocation concealment</p> <p>Blinding of participants and personnel</p> <p>Blinding of outcome assessment (Mortality)</p> <p>Blinding of outcome assessment (LCOS)</p> <p>Blinding of outcome assessment (Secondary outcomes)</p> <p>Blinding of outcome assessment (Safety outcomes)</p> <p>Incomplete outcome data (Mortality)</p> <p>Incomplete outcome data (LCOS)</p> <p>Incomplete outcome data (Secondary outcomes)</p> <p>Incomplete outcome data (Safety outcomes)</p> <p>Selective reporting</p> <p>Other sources of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CONSORT FLOW DIAGRAM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> <div class="table-footnote"> <p>ICU: intensive care unit<br/> LCOS: low cardiac output syndrome </p> </div> </div> </section> <section id="CD009515-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We used 'Risk of bias' tables to list possible concerns over the potential for bias of each individual study, evaluating sequence generation, allocation sequence concealment, blinding of participants, personnel, and outcome assessors, incomplete outcome data, selective outcome reporting, and other potential sources of bias, according to "The Cochrane Collaboration’s tool for assessing risk of bias" (<a href="./references#CD009515-bbs2-0040" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). This was performed independently by two review authors (BB, BS) and any disagreements were settled by discussion. </p> </section> <section id="CD009515-sec-0044"> <h4 class="title">Measures of treatment effect</h4> <p>For total mortality within 30 days, the risk ratio (RR) with 95% confidence interval was used as an effect measure (as for other binary outcomes). Data were pooled using a random‐effects model. </p> <p>For time to death, the effect measure was the log hazard ratio with its standard error. If the hazard ratio or its standard error were not directly reported, it was derived from other reported information if possible (<a href="./references#CD009515-bbs2-0068" title="TierneyJF , StewartLA , GhersiD , BurdettS , SydesMR . Practical methods for incorporating summary time‐to‐event data into meta‐analysis. Trials2007;8:16. ">Tierney 2007</a>). </p> <p>For evaluation of time to extubation (duration of mechanical ventilation), hazard ratios were calculated according to the Cox model. </p> <p>For continuous variables (e.g. if mean and standard deviation of the duration of mechanical ventilation were available instead of hazard ratios), we used the mean difference (MD) with 95% confidence intervals. </p> <p>We assessed binary outcomes (LCOS yes/no, 30‐day mortality) using RR as an effect measure. </p> <p>Data were illustrated using forest plots.</p> </section> <section id="CD009515-sec-0045"> <h4 class="title">Unit of analysis issues</h4> <p>The following outcomes were expected to be reported in repeated measurements of individual study participants at different time intervals following surgery: number of events of low cardiac output syndrome, number of patients requiring mechanical circulatory support, inotrope score. </p> <p>Meta‐analysis of the effect of milrinone with the same comparator (placebo) was only useful within the study by <a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>, since the other studies used different comparison medications. This study used three treatment arms, of which two were assigned to different doses of milrinone (low‐dose group = LD and high‐dose group = HD). Therefore, we treated these as two separate studies for the purposes of the meta‐analysis, dividing the placebo population into two pro‐rata parts for comparison of each of the milrinone groups to one of the two parts of the placebo population, respectively. </p> <p>For the numbers of LCOS and mechanical circulatory support, respectively, the incidence at any time within 30 days after surgery was considered relevant. For the inotrope score, the maximum value reported within 30 days after surgery was used. </p> </section> <section id="CD009515-sec-0046"> <h4 class="title">Dealing with missing data</h4> <p>We contacted study authors and asked them to supply additional information in case of missing data. Some unpublished data were added as a result. </p> </section> <section id="CD009515-sec-0047"> <h4 class="title">Assessment of heterogeneity</h4> <p>Heterogeneity between studies was planned to be assessed using Cochran’s Q and I<sup>2</sup> according to Higgins and Thompson (<a href="./references#CD009515-bbs2-0039" title="HigginsJP , ThompsonSG . Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine2002;21(11):1539‐58. ">Higgins 2002</a>; <a href="./references#CD009515-bbs2-0040" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). Had we noted an I<sup>2</sup> &gt; 50%, we would have performed a subgroup analysis between patients with biventricular surgical repair of a congenital heart defect versus patients after univentricular palliation of a congenital heart defect. </p> </section> <section id="CD009515-sec-0048"> <h4 class="title">Assessment of reporting biases</h4> <p>Wherever protocols of eligible studies were available, we compared the outcomes in the protocols and published reports. Additional information was obtained from all study authors. Funnel plots would have been applied to assess reporting bias if the number of studies had allowed this (<a href="./references#CD009515-bbs2-0038" title="HarbordRM , EggerM , SterneJA . A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints. Statistics in Medicine2006;25(20):3443‐57. ">Harbord 2006</a>), and results would have been adjusted for in an additional sensitivity analysis (<a href="./references#CD009515-bbs2-0057" title="RückerG , SchwarzerG , CarpenterJR , BinderH , SchumacherM . Treatment‐effect estimates adjusted for small‐study effects via a limit meta‐analysis. Biostatistics2011;12(1):122‐42. ">Rücker 2011</a>; <a href="./references#CD009515-bbs2-0060" title="SchwarzerG , RückerG . Statistical methods for detecting and adjusting for publication bias. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen (ZEFQ)2010;104(4):306‐13. ">Schwarzer 2010</a>). </p> </section> <section id="CD009515-sec-0049"> <h4 class="title">Data synthesis</h4> <p>We pooled data using a random‐effects model. For evaluation of time to extubation, hazard ratios (Cox) would have been calculated, if data had been available. For continuous variables, the mean difference (MD) was used. </p> </section> <section id="CD009515-sec-0050"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>With the small numbers of children studied in clinical trials, and owing to the fact that most surgical interventions for congenital heart disease are to date carried out in the first year of life, age‐based subgroup analysis would have been confined to two age groups: infants less than one year of age, and children and adolescents from one to 12 years of age. The infant group comprises children undergoing complicated palliative and corrective operations, necessitating long cardiopulmonary bypass times with concomitant long periods of cardioplegia, and with a high risk of morbidity and mortality. On the other hand, in the group of children ≥ 1 year old, there is a higher proportion of less complicated and lengthy procedures, which leads to an a priori lower morbidity and mortality risk. </p> <p>Furthermore, two subgroups were pre‐defined based on cardiovascular physiology:</p> <p> <ol id="CD009515-list-0006"> <li> <p>children with biventricular surgical repair of a congenital heart defect versus</p> </li> <li> <p>children after univentricular palliation of a congenital heart defect.</p> </li> </ol> </p> </section> <section id="CD009515-sec-0051"> <h4 class="title">Sensitivity analysis</h4> <p>We expected to find studies with different levels of risk of bias. For a sensitivity analysis, studies with high risk of bias would have been excluded. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009515-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009515-sec-0052"></div> <section id="CD009515-sec-0053"> <h3 class="title">Description of studies</h3> <section id="CD009515-sec-0054"> <h4 class="title">Results of the search</h4> <p>Electronic database searching yielded 1023 records by September 2014. From these, 349 records were removed as duplicates. A total of 656 records were excluded by screening, leaving 18 full‐text articles to be assessed, one of which was a partial duplicate (conference abstract and full report of the same study). </p> <p>Registry searches yielded a total of 112 records on 29 February 2012 (Clinicaltrials.gov: 11, EU clinical trials register: seven, WHO International Clinical Trials Registry Platform: 11, metaRegister of current controlled trials: 23, International Federation of Pharmaceutical Manufacturers &amp; Associations Clinical Trials Portal: 59, Forschungsdatenbank Universität Zürich: one), of which 101 were removed by screening, and of the remaining 11, nine were duplicates and two were excluded. </p> <p>References from reviews yielded an additional 14 records, of which seven were duplicates and the remaining seven were removed by screening. </p> <p>Expert consultation yielded no additional studies. The manufacturer did not answer our request about possible unpublished data. </p> <p>From all sources, we assessed 20 full‐text articles for eligibility, and 12 of them were excluded. The remaining eight articles described six studies, five of which were included in the qualitative and quantitative synthesis and one remains unclassified so far (<a href="./references#CD009515-bbs2-0020" title="CostelloJM , Dunbar‐MastersonC , AllanCK , GauvreauK , NewburgerJW , McGowanFXJr , et al. Impact of empiric nesiritide or milrinone infusion on early postoperative recovery after Fontan surgery: a randomized, double‐blind, placebo‐controlled trial. Circulation Heart Failure2014;7(4):596‐604. CostelloJM , MastersonCD , AllanCK , GauvreauK , NewburgerJW , McGowanFX , et al. Impact of empiric nesiritide or milrinone infusion on early postoperative recovery following fontan surgery: A randomized, double‐blind, placebo‐controlled clinical trial. Circulation. 2013; Vol. 128(22 suppl):A12099. ">Costello 2014</a>, <a href="./references#CD009515-sec-0088" title="">Characteristics of studies awaiting classification</a>). </p> <p>See <a href="#CD009515-fig-0001">Figure 1</a> for the study flow diagram. </p> <div class="figure" id="CD009515-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD009515-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD009515-sec-0055"> <h4 class="title">Included studies</h4> <p>Of the included studies (see also <a href="./references#CD009515-sec-0086" title="">Characteristics of included studies</a> below), one compared milrinone versus placebo (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>), three compared milrinone versus levosimendan (<a href="./references#CD009515-bbs2-0005" title="LechnerE , HoferA , Leitner‐PenederG , FreynschlagR , MairR , WeinzettelR , et al. Levosimendan versus milrinone in neonates and infants after corrective open‐heart surgery: a pilot study. Pediatric Critical Care Medicine2012;13(5):542‐8. ">Lechner 2012</a>; <a href="./references#CD009515-bbs2-0006" title="MomeniM , RubayJ , MattaA , RennotteMT , VeyckemansF , PonceletAJ , et al. Levosimendan in congenital cardiac surgery: a randomized, double‐blind clinical trial. Journal of Cardiothoracic and Vascular Anesthesia2011;25(3):419‐24. ">Momeni 2011</a>; <a href="./references#CD009515-bbs2-0007" title="PellicerA , RieraJ , Lopez‐OrtegoP , BravoMC , MaderoR , Perez‐RodriguezJ , et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research2013;73(1):95‐103. ">Pellicer 2013</a>), and one study compared milrinone with dobutamine (<a href="./references#CD009515-bbs2-0001" title="Cavigelli‐BrunnerA , HugMI , DaveH , CannizzaroV , BaenzigerO , BuerkiC , et al. Therapy of low cardiac output syndrome after cardiac surgery in infants and children: a double blind randomized study comparing dobutamine and milrinone. Cardiology in the Young. May 2013; Vol. 23, Supplement S1:S34; O11‐3. ">Cavigelli 2013</a>). </p> <p>All studies were conducted in one or more tertiary care children's hospitals. All included neonates, and in addition, all except one study (<a href="./references#CD009515-bbs2-0007" title="PellicerA , RieraJ , Lopez‐OrtegoP , BravoMC , MaderoR , Perez‐RodriguezJ , et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research2013;73(1):95‐103. ">Pellicer 2013</a>) included infants beyond four weeks corrected gestational age, with one study (<a href="./references#CD009515-bbs2-0005" title="LechnerE , HoferA , Leitner‐PenederG , FreynschlagR , MairR , WeinzettelR , et al. Levosimendan versus milrinone in neonates and infants after corrective open‐heart surgery: a pilot study. Pediatric Critical Care Medicine2012;13(5):542‐8. ">Lechner 2012</a>) concentrating on patients one year old or younger. None examined subgroups of patients, neither by age nor by type of cardiac disease. Patients with single ventricle participated in one study only constituting four out of 50 participants) (<a href="./references#CD009515-bbs2-0001" title="Cavigelli‐BrunnerA , HugMI , DaveH , CannizzaroV , BaenzigerO , BuerkiC , et al. Therapy of low cardiac output syndrome after cardiac surgery in infants and children: a double blind randomized study comparing dobutamine and milrinone. Cardiology in the Young. May 2013; Vol. 23, Supplement S1:S34; O11‐3. ">Cavigelli 2013</a>). The duration of study drug administration ranged from 24 to 48 hours, and follow‐up periods ranged from six to 78 days. </p> <p>None of the studies evaluated time to death or adverse events as designated in our protocol. LCOS according to our definition was a defined outcome only in the <a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a> study. It could be reconstructed (unpublished data) by the authors of two of the levosimendan studies (<a href="./references#CD009515-bbs2-0005" title="LechnerE , HoferA , Leitner‐PenederG , FreynschlagR , MairR , WeinzettelR , et al. Levosimendan versus milrinone in neonates and infants after corrective open‐heart surgery: a pilot study. Pediatric Critical Care Medicine2012;13(5):542‐8. ">Lechner 2012</a>; <a href="./references#CD009515-bbs2-0007" title="PellicerA , RieraJ , Lopez‐OrtegoP , BravoMC , MaderoR , Perez‐RodriguezJ , et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research2013;73(1):95‐103. ">Pellicer 2013</a>), but not by the others, because not all of the parameters constituting this composite outcome were part of the endpoints of the other trials. </p> <p>Only children who had undergone cardiopulmonary bypass were included.</p> </section> <section id="CD009515-sec-0056"> <h4 class="title">Excluded studies</h4> <p>The studies excluded (see also <a href="./references#CD009515-sec-0087" title="">Characteristics of excluded studies</a> below) were not considered for review because of adult participants (e.g. <a href="./references#CD009515-bbs2-0011" title="CarmonaMJ , MartinsLM , VaneMF , LongoBA , ParedesLS , MalbouissonLM . Comparison of the effects of dobutamine and milrinone on hemodynamic parameters and oxygen supply in patients undergoing cardiac surgery with low cardiac output after anesthetic induction. Revista Brasileira de Anestesiologia2010;60(3):237‐46. ">Carmona 2010</a>) or due to different outcomes, e.g. only pulmonary artery pressures and resistances reported (<a href="./references#CD009515-bbs2-0009" title="CaiJ , SuZ , ShiZ , ZhouY , XuZ , XuZ , et al. Nitric oxide and milrinone: combined effect on pulmonary circulation after Fontan‐type procedure: a prospective, randomized study. Annals of Thoracic Surgery2008;86(3):882‐8. ">Cai 2008a</a>). </p> </section> </section> <section id="CD009515-sec-0057"> <h3 class="title">Risk of bias in included studies</h3> <p>Three trials were considered at low risk of bias while two were considered at higher risk of bias. In cases of incomplete descriptions in the published articles, we sought additional information from the study authors, leading mostly to assessment as a low risk of bias (see 'Risk of bias' tables and <a href="#CD009515-fig-0002">Figure 2</a> and <a href="#CD009515-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD009515-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009515-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD009515-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009515-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> </section> <section id="CD009515-sec-0058"> <h3 class="title" id="CD009515-sec-0058">Effects of interventions</h3> <section id="CD009515-sec-0059"> <h4 class="title">Primary outcomes:</h4> <p>a) Total mortality within 30 days: Data available from the included trials are insufficient for additional comparisons. There was no 30‐day mortality in two trials (<a href="./references#CD009515-bbs2-0005" title="LechnerE , HoferA , Leitner‐PenederG , FreynschlagR , MairR , WeinzettelR , et al. Levosimendan versus milrinone in neonates and infants after corrective open‐heart surgery: a pilot study. Pediatric Critical Care Medicine2012;13(5):542‐8. ">Lechner 2012</a> and <a href="./references#CD009515-bbs2-0001" title="Cavigelli‐BrunnerA , HugMI , DaveH , CannizzaroV , BaenzigerO , BuerkiC , et al. Therapy of low cardiac output syndrome after cardiac surgery in infants and children: a double blind randomized study comparing dobutamine and milrinone. Cardiology in the Young. May 2013; Vol. 23, Supplement S1:S34; O11‐3. ">Cavigelli 2013</a>), no in‐hospital mortality among the patients who received the study drug postoperatively in one trial (<a href="./references#CD009515-bbs2-0006" title="MomeniM , RubayJ , MattaA , RennotteMT , VeyckemansF , PonceletAJ , et al. Levosimendan in congenital cardiac surgery: a randomized, double‐blind clinical trial. Journal of Cardiothoracic and Vascular Anesthesia2011;25(3):419‐24. ">Momeni 2011</a>), three deaths during the 48‐hour study period (2/9 in the milrinone group and 1/11 in the comparison group) in one trial (<a href="./references#CD009515-bbs2-0007" title="PellicerA , RieraJ , Lopez‐OrtegoP , BravoMC , MaderoR , Perez‐RodriguezJ , et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research2013;73(1):95‐103. ">Pellicer 2013</a>), and no mortality during the 36‐hour study drug infusion period in the largest trial (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>), which also reports two later deaths (2/238 = 0.8% of patients), thought to be unrelated to the study drug but does not expressly report which study group these patients had been part of (the high‐dose group according to <a href="./references#CD009515-bbs2-0048" title="Medicines and Healthcare Products Regulatory Agency (UK), Paediatric Working Party ‐ Committee on Safety of Medicines. Review of paediatric data ‐ Primacor Injection. http://www.mhra.gov.uk/home/groups/pl‐p/documents/websiteresources/con2030490.pdf 2005, Apr 27; Vol. Accessed 2014, Sep 11. ">MHRA 2005</a>). </p> <p>For the comparison of mortality of patients treated with milrinone versus levosimendan (<a href="./references#CD009515-fig-0006" title="">Analysis 1.1</a>, mortality milrinone versus levosimendan), in two studies (<a href="./references#CD009515-bbs2-0005" title="LechnerE , HoferA , Leitner‐PenederG , FreynschlagR , MairR , WeinzettelR , et al. Levosimendan versus milrinone in neonates and infants after corrective open‐heart surgery: a pilot study. Pediatric Critical Care Medicine2012;13(5):542‐8. ">Lechner 2012</a>; <a href="./references#CD009515-bbs2-0006" title="MomeniM , RubayJ , MattaA , RennotteMT , VeyckemansF , PonceletAJ , et al. Levosimendan in congenital cardiac surgery: a randomized, double‐blind clinical trial. Journal of Cardiothoracic and Vascular Anesthesia2011;25(3):419‐24. ">Momeni 2011</a>), no events were observed in any group. Therefore, these studies are omitted from the analysis, although they contribute more patients than the third study (<a href="./references#CD009515-bbs2-0007" title="PellicerA , RieraJ , Lopez‐OrtegoP , BravoMC , MaderoR , Perez‐RodriguezJ , et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research2013;73(1):95‐103. ">Pellicer 2013</a>), which contributed two events in the milrinone group and one event in the levosimendan group (risk ratio (RR) 2.44, 95% confidence interval (CI) 0.26 to 22.80). As a sensitivity analysis, we used a constant continuity correction of 0.5 for all groups of all studies (CCC) and also treatment arm continuity correction (TAC) (<a href="./references#CD009515-bbs2-0065" title="SweetingMJ , SuttonAJ , LambertPC . What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse data. Statistics in Medicine2004;23(9):1351‐75. ">Sweeting 2004</a>). The pooled results were (CCC) RR 1.61, (95% CI 0.35 to 7.38) and (TAC) RR1.58, (95% CI 0.35 to 7.18). These results indicate a risk ratio nearer to one than that of the primary analysis with more precision, that is, there is even less reason to assume a difference in mortality between milrinone and levosimendan than by using the primary analysis (see <a href="./references#CD009515-fig-0006" title="">Analysis 1.1</a>, <a href="#CD009515-fig-0004">Figure 4</a>, and <a href="#CD009515-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD009515-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Mortality, outcome: 1.1 Mortality milrinone versus levosimendan, Constant Continuity Correction.event.e = event in experimental group; n.e. = non‐event in experimental group; incr.e. = increment experimental group.event.c = event in control group; n.c. = non‐event in control group; incr.c. = increment control group." data-id="CD009515-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Mortality, outcome: 1.1 Mortality milrinone versus levosimendan, Constant Continuity Correction. </p> <p>event.e = event in experimental group; n.e. = non‐event in experimental group; incr.e. = increment experimental group. </p> <p>event.c = event in control group; n.c. = non‐event in control group; incr.c. = increment control group. </p> </div> </div> </div> <div class="figure" id="CD009515-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Mortality, outcome: 1.1 Mortality milrinone versus levosimendan, Treatment Arm Continuity Correction.event.e = event in experimental group; n.e. = non‐event in experimental group; incr.e. = increment experimental group.event.c = event in control group; n.c. = non‐event in control group; incr.c. = increment control group." data-id="CD009515-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Mortality, outcome: 1.1 Mortality milrinone versus levosimendan, Treatment Arm Continuity Correction. </p> <p>event.e = event in experimental group; n.e. = non‐event in experimental group; incr.e. = increment experimental group. </p> <p>event.c = event in control group; n.c. = non‐event in control group; incr.c. = increment control group. </p> </div> </div> </div> <p>b) Time to death (censored after three months): not reported in any of the included studies. </p> <p>c) Low cardiac output syndrome: The study comparing milrinone to placebo (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>) used three treatment arms, of which two were assigned to different doses of milrinone (low‐dose group = LD and high‐dose group = HD). Therefore, we treated these as two separate studies for the purposes of the meta‐analysis, dividing the placebo population into two approximately equal parts for comparison of each milrinone group with one of the two halves of the placebo population, respectively. The incidence of LCOS in the first 36 hours postoperatively was lower in the milrinone group compared to placebo, (RR 0.52, 95% CI 0.28 to 0.96) (<a href="./references#CD009515-fig-0007" title="">Analysis 2.1</a>). Unfortunately, the study population in this trial (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>) showed a high attrition rate of over two thirds of the incidence of LCOS and missing data as to which groups the drop outs had belonged. Therefore, only data up to 36 hours follow‐up for LCOS could be used, which was the duration of postoperative study drug infusion. When considering high‐dose milrinone versus placebo separately, milrinone performed better than placebo for LCOS prevention within 36 hours after surgery, with a RR 0.35, (95% CI 0.15 to 0.86; 73 patients in the experimental and 37 in the pro‐rata placebo group). In contrast, the comparison of low‐dose milrinone versus placebo failed to show superiority of prophylactic milrinone in preventing LCOS (RR 0.67, 95% CI 0.33 to 1.37, with 79 patients in the experimental and 38 in the pro‐rata placebo group). However, there were no detectable subgroup differences, with a non‐significant heterogeneity (P = 0.27; I² = 19%) between the high‐dose milrinone versus placebo and the low‐dose milrinone versus placebo study components. </p> <p>When comparing milrinone to levosimendan, no statistically significant difference was found (RR 1.22, 95% CI 0.32 to 4.65, with 29 patients in the milrinone group and 30 patients in the levosimendan group) (<a href="./references#CD009515-fig-0007" title="">Analysis 2.1</a>). The study comparing milrinone to dobutamine (<a href="./references#CD009515-bbs2-0001" title="Cavigelli‐BrunnerA , HugMI , DaveH , CannizzaroV , BaenzigerO , BuerkiC , et al. Therapy of low cardiac output syndrome after cardiac surgery in infants and children: a double blind randomized study comparing dobutamine and milrinone. Cardiology in the Young. May 2013; Vol. 23, Supplement S1:S34; O11‐3. ">Cavigelli 2013</a>) did not use LCOS as a defined outcome. </p> </section> <section id="CD009515-sec-0060"> <h4 class="title">Secondary outcomes:</h4> <p>a) Duration of intensive care stay: Data are shown in <a href="./references#CD009515-fig-0008" title="">Analysis 3.1</a>. When using the numbers of the two trials comparing milrinone (38 patients) with levosimendan (37 patients), the resulting mean difference (MD) is ‐0.18 days with a 95% CI of ‐4.36 to 4.00 days. The other trial reporting on this outcome compared milrinone (24 patients) with dobutamine (26 patients) and did not show any differences either (MD 0.30 days, 95% CI ‐0.71 to 1.31 days). </p> <p>b) Duration of hospital stay: Data are shown in <a href="./references#CD009515-fig-0009" title="">Analysis 4.1</a>. For the comparison of milrinone versus placebo (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>), a population of 209 patients is assumed after drop outs lost to follow‐up; however, only means are reported, not standard deviations, which therefore do not lend themselves to meta‐analysis. When taking into account milrinone versus levosimendan (38 versus 37 patients, respectively) and milrinone versus dobutamine (24 versus 26 patients), there is no significant difference in duration of hospital stay with either of these prophylactic medications (MD 0.72, 95% CI ‐2.75 to 4.19). </p> <p>c) Duration of mechanical ventilation: Data are shown in <a href="./references#CD009515-fig-0010" title="">Analysis 5.1</a>. For the comparison of milrinone versus placebo (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>), the population of 209 patients is assumed after drop outs lost to follow‐up; however, only means are reported, not standard deviations, which therefore do not lend themselves to meta‐analysis. When taking into account milrinone versus levosimendan (38 versus 37 patients, respectively) and milrinone versus dobutamine (24 versus 26 patients), there is no significant difference in duration of mechanical ventilation with either of these prophylactic medications (MD 0.12, 95% CI ‐1.00 to 1.24). </p> <p>d) Inotrope score: Data are shown in <a href="./references#CD009515-fig-0011" title="">Analysis 6.1</a>. Data are available by patient groups from two studies comparing milrinone to levosimendan (<a href="./references#CD009515-bbs2-0005" title="LechnerE , HoferA , Leitner‐PenederG , FreynschlagR , MairR , WeinzettelR , et al. Levosimendan versus milrinone in neonates and infants after corrective open‐heart surgery: a pilot study. Pediatric Critical Care Medicine2012;13(5):542‐8. ">Lechner 2012</a> and <a href="./references#CD009515-bbs2-0007" title="PellicerA , RieraJ , Lopez‐OrtegoP , BravoMC , MaderoR , Perez‐RodriguezJ , et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research2013;73(1):95‐103. ">Pellicer 2013</a>), with the maximum inotrope score reached in the milrinone groups after 24 hours (<a href="./references#CD009515-bbs2-0005" title="LechnerE , HoferA , Leitner‐PenederG , FreynschlagR , MairR , WeinzettelR , et al. Levosimendan versus milrinone in neonates and infants after corrective open‐heart surgery: a pilot study. Pediatric Critical Care Medicine2012;13(5):542‐8. ">Lechner 2012</a>) and after 12 hours (<a href="./references#CD009515-bbs2-0007" title="PellicerA , RieraJ , Lopez‐OrtegoP , BravoMC , MaderoR , Perez‐RodriguezJ , et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research2013;73(1):95‐103. ">Pellicer 2013</a>), respectively, versus after 18 hours in the levosimendan group (both studies, numbers taken from figure 4, page 547, <a href="./references#CD009515-bbs2-0005" title="LechnerE , HoferA , Leitner‐PenederG , FreynschlagR , MairR , WeinzettelR , et al. Levosimendan versus milrinone in neonates and infants after corrective open‐heart surgery: a pilot study. Pediatric Critical Care Medicine2012;13(5):542‐8. ">Lechner 2012</a>). </p> <p>The original published report of another study (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>) did not report absolute or maximum inotrope scores, but claimed "no statistically significant differences among the 3 treatment groups with respect to [...] baseline inotropic support". Inotropic medication was increased or added in patients who developed LCOS. In an external publication detailing more data from this trial (<a href="./references#CD009515-bbs2-0048" title="Medicines and Healthcare Products Regulatory Agency (UK), Paediatric Working Party ‐ Committee on Safety of Medicines. Review of paediatric data ‐ Primacor Injection. http://www.mhra.gov.uk/home/groups/pl‐p/documents/websiteresources/con2030490.pdf 2005, Apr 27; Vol. Accessed 2014, Sep 11. ">MHRA 2005</a>), initiation of pharmacological support was necessary in the intention‐to‐treat population's placebo group in 18 of 81 patients (22.2%), less frequently in the low‐dose milrinone group, that is in 14 of 80 patients (17.5%), and even less frequently in the high‐dose milrinone group, that is in five of 77 patients (6.5%). This is significantly higher for the placebo group than for the high‐dose milrinone group with a RR 0.29, 95% CI 0.10 to 0.80 and results in an overall RR of 0.51, 95% CI 0.19 to 1.37 for patients treated with any dose of prophylactic milrinone compared to patients on placebo. Escalation of existing pharmacological support was evenly distributed in the groups with six of 81 patients affected in the placebo group (7.4%), six of 80 patients in the low‐dose milrinone group (7.5%), and seven of 77 patients in the high‐dose milrinone group (9.1%). </p> <p>e) Number of patients requiring mechanical circulatory support (e.g. ECMO, pulsatile assist devices) or cardiac transplantation: Mechanical circulatory support was rarely used. There was one out of 11 patients of the comparison group in one of the milrinone versus levosimendan trials (<a href="./references#CD009515-bbs2-0007" title="PellicerA , RieraJ , Lopez‐OrtegoP , BravoMC , MaderoR , Perez‐RodriguezJ , et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research2013;73(1):95‐103. ">Pellicer 2013</a>) and two out of 209 patients (population with complete follow‐up) in the milrinone versus placebo trial (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>) who needed extracorporeal membrane oxygenation, one in the high‐dose milrinone arm and one in the placebo arm (<a href="./references#CD009515-bbs2-0048" title="Medicines and Healthcare Products Regulatory Agency (UK), Paediatric Working Party ‐ Committee on Safety of Medicines. Review of paediatric data ‐ Primacor Injection. http://www.mhra.gov.uk/home/groups/pl‐p/documents/websiteresources/con2030490.pdf 2005, Apr 27; Vol. Accessed 2014, Sep 11. ">MHRA 2005</a>). None of the participants of the other studies who had received the study drug for at least four hours needed mechanical circulatory support. No patient from any of the included studies received a heart transplantation during the study or during the respective follow‐up period. </p> </section> <section id="CD009515-sec-0061"> <h4 class="title">Safety outcomes:</h4> <p>a) Arrhythmias (number/proportion): Two studies (<a href="./references#CD009515-bbs2-0005" title="LechnerE , HoferA , Leitner‐PenederG , FreynschlagR , MairR , WeinzettelR , et al. Levosimendan versus milrinone in neonates and infants after corrective open‐heart surgery: a pilot study. Pediatric Critical Care Medicine2012;13(5):542‐8. ">Lechner 2012</a>; <a href="./references#CD009515-bbs2-0006" title="MomeniM , RubayJ , MattaA , RennotteMT , VeyckemansF , PonceletAJ , et al. Levosimendan in congenital cardiac surgery: a randomized, double‐blind clinical trial. Journal of Cardiothoracic and Vascular Anesthesia2011;25(3):419‐24. ">Momeni 2011</a>) had no incidences of arrhythmia. The largest study (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>) reported two patients (out of the assumed per protocol population of 227 patients) with arrhythmias but did not report which treatment groups they belonged to. Nodal arrhythmias were however reported to the UK regulatory agency (<a href="./references#CD009515-bbs2-0048" title="Medicines and Healthcare Products Regulatory Agency (UK), Paediatric Working Party ‐ Committee on Safety of Medicines. Review of paediatric data ‐ Primacor Injection. http://www.mhra.gov.uk/home/groups/pl‐p/documents/websiteresources/con2030490.pdf 2005, Apr 27; Vol. Accessed 2014, Sep 11. ">MHRA 2005</a>) by the manufacturer at a frequency of two (2.5%) of 81 patients in the placebo group, six (7.5%) of 80 patients in the low‐dose milrinone group, and eight (10.4%) of 77 patients in the high‐dose milrinone group. </p> <p>The remaining two studies report one of nine patients in the milrinone group and two of 11 patients in the levosimendan group with AV conduction abnormalities (RR 0.61, 95% CI 0.07 to 5.70) (<a href="./references#CD009515-bbs2-0007" title="PellicerA , RieraJ , Lopez‐OrtegoP , BravoMC , MaderoR , Perez‐RodriguezJ , et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research2013;73(1):95‐103. ">Pellicer 2013</a>), and seven of 24 patients (29%) in the milrinone group and four of 26 (15%) patients in the dobutamine group with arrhythmias (third degree atrio‐ventricular block (permanent or transient), second degree atrio‐ventricular block (Wenckebach type), junctional ectopic tachycardia, supraventricular tachycardia, atrial ectopic tachycardia) (RR 1.90, 95% CI 0.63 to 5.67) (<a href="./references#CD009515-bbs2-0001" title="Cavigelli‐BrunnerA , HugMI , DaveH , CannizzaroV , BaenzigerO , BuerkiC , et al. Therapy of low cardiac output syndrome after cardiac surgery in infants and children: a double blind randomized study comparing dobutamine and milrinone. Cardiology in the Young. May 2013; Vol. 23, Supplement S1:S34; O11‐3. ">Cavigelli 2013</a>), respectively. </p> <p>Meta‐analysis of the effect of milrinone with the same comparator (placebo) was performed within the study by <a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>, since the other studies used different comparison medications. This study used three treatment arms, of which two were assigned to different doses of milrinone (low‐dose group = LD and high‐dose group = HD). Therefore, we treated these as two separate studies for the purposes of the meta‐analysis, dividing the placebo population into two pro‐rata parts for comparison of each of the milrinone groups to one of the two parts of the placebo population, respectively. The incidence of arrhythmias was higher in the milrinone group compared to placebo, with the 95% confidence interval of the risk ratio still including 1, (RR 3.59, 95% CI 0.83 to 15.42. </p> <p>When looking at all patients receiving milrinone versus different kinds of other interventions, the included studies did not prove an increased risk of arrhythmia in the milrinone groups (RR 1.99, 95% CI 0.88 to 4.50) (<a href="./references#CD009515-fig-0012" title="">Analysis 7.1</a>). </p> <p>b) Tachycardia (number/proportion of patients with heart rate above heart rate appropriate for age or body surface area): Tachycardia was part of the LCOS definition in one study (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>), which does not report cutoff values or patient numbers with tachycardia. Tachycardia occurred in 14 of 24 patients (58%) in the milrinone group versus 22 of 26 patients (85%) in the dobutamine group in one study (<a href="./references#CD009515-bbs2-0001" title="Cavigelli‐BrunnerA , HugMI , DaveH , CannizzaroV , BaenzigerO , BuerkiC , et al. Therapy of low cardiac output syndrome after cardiac surgery in infants and children: a double blind randomized study comparing dobutamine and milrinone. Cardiology in the Young. May 2013; Vol. 23, Supplement S1:S34; O11‐3. ">Cavigelli 2013</a>). All other studies reported no incidence of tachycardia. A meta‐analysis for this outcome is therefore not possible. </p> <p>c) Hypotension (number/proportion of patients with blood pressures below blood pressure appropriate for age or body surface area): Data from all studies are not comparable due to the different types of blood pressures recorded and manners of reporting. The largest trial (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>) reports hypotension (the definition of which is not mentioned) in one patient each in the placebo (1.2%) and low‐dose (1.3%) arms and in two patients (2.6%) in the high‐dose arm, which amounted to no differences between the groups. The manufacturer's report to the UK regulatory agency (<a href="./references#CD009515-bbs2-0048" title="Medicines and Healthcare Products Regulatory Agency (UK), Paediatric Working Party ‐ Committee on Safety of Medicines. Review of paediatric data ‐ Primacor Injection. http://www.mhra.gov.uk/home/groups/pl‐p/documents/websiteresources/con2030490.pdf 2005, Apr 27; Vol. Accessed 2014, Sep 11. ">MHRA 2005</a>) mentions hypotension as an adverse event in 10 of 81 (12.3%) patients of the placebo group, in three of 80 (3.8%) patients in the low‐dose milrinone group, and in 10 (13%) of 77 patients in the high‐dose milrinone group. </p> <p>One trial reports diastolic blood pressure means (<a href="./references#CD009515-bbs2-0007" title="PellicerA , RieraJ , Lopez‐OrtegoP , BravoMC , MaderoR , Perez‐RodriguezJ , et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research2013;73(1):95‐103. ">Pellicer 2013</a>), while there are systolic blood pressure data displayed in figures from one of the levosimendan trials (<a href="./references#CD009515-bbs2-0005" title="LechnerE , HoferA , Leitner‐PenederG , FreynschlagR , MairR , WeinzettelR , et al. Levosimendan versus milrinone in neonates and infants after corrective open‐heart surgery: a pilot study. Pediatric Critical Care Medicine2012;13(5):542‐8. ">Lechner 2012</a>): systolic blood pressure means with standard error of means markings (unclear which markings belong to which treatment arm) and diastolic blood pressure means with standard deviation markings in the dobutamine trial (<a href="./references#CD009515-bbs2-0001" title="Cavigelli‐BrunnerA , HugMI , DaveH , CannizzaroV , BaenzigerO , BuerkiC , et al. Therapy of low cardiac output syndrome after cardiac surgery in infants and children: a double blind randomized study comparing dobutamine and milrinone. Cardiology in the Young. May 2013; Vol. 23, Supplement S1:S34; O11‐3. ">Cavigelli 2013</a>). Numerical data of mean arterial blood pressure means and standard deviations are available for one of the levosimendan trials (<a href="./references#CD009515-bbs2-0006" title="MomeniM , RubayJ , MattaA , RennotteMT , VeyckemansF , PonceletAJ , et al. Levosimendan in congenital cardiac surgery: a randomized, double‐blind clinical trial. Journal of Cardiothoracic and Vascular Anesthesia2011;25(3):419‐24. ">Momeni 2011</a>), and of systolic arterial blood pressure means and standard deviations from the dobutamine trial (<a href="./references#CD009515-bbs2-0001" title="Cavigelli‐BrunnerA , HugMI , DaveH , CannizzaroV , BaenzigerO , BuerkiC , et al. Therapy of low cardiac output syndrome after cardiac surgery in infants and children: a double blind randomized study comparing dobutamine and milrinone. Cardiology in the Young. May 2013; Vol. 23, Supplement S1:S34; O11‐3. ">Cavigelli 2013</a>). </p> <p>However, our review definition of blood pressure values below those appropriate for patient age and body surface area at any point in time was not reported in any of the studies. A meta‐analysis of the effect of milrinone on the incidence of hypotension was not done due to the inconsistency of definition and reported values across studies. </p> <p>d) Intraventricular haemorrhage (IVH) (number/proportion): This adverse event is not mentioned in the largest trial (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>) and in one of the levosimendan trials (<a href="./references#CD009515-bbs2-0006" title="MomeniM , RubayJ , MattaA , RennotteMT , VeyckemansF , PonceletAJ , et al. Levosimendan in congenital cardiac surgery: a randomized, double‐blind clinical trial. Journal of Cardiothoracic and Vascular Anesthesia2011;25(3):419‐24. ">Momeni 2011</a>), and there were no cases of IVH in two trials (<a href="./references#CD009515-bbs2-0001" title="Cavigelli‐BrunnerA , HugMI , DaveH , CannizzaroV , BaenzigerO , BuerkiC , et al. Therapy of low cardiac output syndrome after cardiac surgery in infants and children: a double blind randomized study comparing dobutamine and milrinone. Cardiology in the Young. May 2013; Vol. 23, Supplement S1:S34; O11‐3. ">Cavigelli 2013</a>; <a href="./references#CD009515-bbs2-0005" title="LechnerE , HoferA , Leitner‐PenederG , FreynschlagR , MairR , WeinzettelR , et al. Levosimendan versus milrinone in neonates and infants after corrective open‐heart surgery: a pilot study. Pediatric Critical Care Medicine2012;13(5):542‐8. ">Lechner 2012</a>). There were two of nine patients (22.2%) in the milrinone group with IVH of any grade and none of 11 patients (0%) in the comparison group in one of the levosimendan trials (<a href="./references#CD009515-bbs2-0007" title="PellicerA , RieraJ , Lopez‐OrtegoP , BravoMC , MaderoR , Perez‐RodriguezJ , et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research2013;73(1):95‐103. ">Pellicer 2013</a>), which however reports other new pathological cranial ultrasound findings in one of nine patients (11.1%) in the milrinone group and two of 11 patients (18.2%) in the comparison group. One other case of a pathological cranial ultrasound finding also occurred in one of 20 patients in the milrinone group and none out of 20 patients in the comparison group in one of the other levosimendan trials (<a href="./references#CD009515-bbs2-0005" title="LechnerE , HoferA , Leitner‐PenederG , FreynschlagR , MairR , WeinzettelR , et al. Levosimendan versus milrinone in neonates and infants after corrective open‐heart surgery: a pilot study. Pediatric Critical Care Medicine2012;13(5):542‐8. ">Lechner 2012</a>). </p> <p>e) Hypokalaemia (number/proportion): No incidence of hypokalaemia was found in one trial (<a href="./references#CD009515-bbs2-0007" title="PellicerA , RieraJ , Lopez‐OrtegoP , BravoMC , MaderoR , Perez‐RodriguezJ , et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research2013;73(1):95‐103. ">Pellicer 2013</a>), whereas one other trial (<a href="./references#CD009515-bbs2-0001" title="Cavigelli‐BrunnerA , HugMI , DaveH , CannizzaroV , BaenzigerO , BuerkiC , et al. Therapy of low cardiac output syndrome after cardiac surgery in infants and children: a double blind randomized study comparing dobutamine and milrinone. Cardiology in the Young. May 2013; Vol. 23, Supplement S1:S34; O11‐3. ">Cavigelli 2013</a>) reports hypokalaemia in 15 of 24 patients (62.5%) in the milrinone group and in 15 of 26 patients (57.7%) in the dobutamine group. All other trials did not assess this adverse reaction. </p> <p>f) Bronchospasm (number/proportion): No incidences of bronchospasm are reported in any trial. </p> <p>g) Thrombocytopenia (number/proportion): Using a definition of thrombocytopenia of a platelet count &lt; 50,000/mm<sup>3</sup>, one trial (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>) found no difference in the incidence between the study groups at three different times of measurement. During the study drug infusion (first 36 hours), incidences were 7.4% in the placebo arm, 8.8% in the low‐dose milrinone arm, and 2.6% in the high‐dose milrinone arm, respectively. According to the numbers of the per protocol population, this equals roughly six of 75 patients in the placebo group, seven of 79 patients in the low‐dose milrinone group, and two of 73 patients in the high‐dose milrinone group, respectively. The manufacturer's information to the UK regulatory agency (<a href="./references#CD009515-bbs2-0048" title="Medicines and Healthcare Products Regulatory Agency (UK), Paediatric Working Party ‐ Committee on Safety of Medicines. Review of paediatric data ‐ Primacor Injection. http://www.mhra.gov.uk/home/groups/pl‐p/documents/websiteresources/con2030490.pdf 2005, Apr 27; Vol. Accessed 2014, Sep 11. ">MHRA 2005</a>) reports nine out of 81 patients in the placebo group (11.1%), eight out of 80 patients in the low‐dose milrinone group (10%), and seven out of 77 patients in the high‐dose milrinone group (9.1%) who developed thrombocytopenia, respectively. <a href="./references#CD009515-fig-0013" title="">Analysis 8.1</a> compares the treatment arms in this trial, with the placebo group split approximately equally between the high‐dose and the low‐dose arms of the study, thus treating them as separate studies with the same endpoint. The risk ratio of developing thrombocytopenia is 0.86 (95% CI 0.39 to 1.88) in the milrinone groups compared to placebo (<a href="./references#CD009515-bbs2-0002" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman (HD vs. placebo)</a>; (<a href="./references#CD009515-bbs2-0003" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman (LD vs. placebo)</a>, with a total of 157 participants in the milrinone groups and 81 participants in the placebo groups). </p> <p>No thrombocytopenia occurred in one of the levosimendan trials (<a href="./references#CD009515-bbs2-0007" title="PellicerA , RieraJ , Lopez‐OrtegoP , BravoMC , MaderoR , Perez‐RodriguezJ , et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research2013;73(1):95‐103. ">Pellicer 2013</a>), and a high incidence of thrombocytopenia was reported in the dobutamine trial (<a href="./references#CD009515-bbs2-0001" title="Cavigelli‐BrunnerA , HugMI , DaveH , CannizzaroV , BaenzigerO , BuerkiC , et al. Therapy of low cardiac output syndrome after cardiac surgery in infants and children: a double blind randomized study comparing dobutamine and milrinone. Cardiology in the Young. May 2013; Vol. 23, Supplement S1:S34; O11‐3. ">Cavigelli 2013</a>), where 23 of 24 patients in the milrinone group (95.8%) and 23 of 26 patients in the comparison group (88.5%) had platelet counts below 80% of their individual baseline values. Thrombocytopenia was not assessed in the other trials. </p> <p>h) Elevated serum levels of liver enzymes (number/proportion of patients with serum enzymatic activities more than two‐fold the age‐appropriate normal values): Serum levels of liver enzymes were only assessed in one trial (<a href="./references#CD009515-bbs2-0007" title="PellicerA , RieraJ , Lopez‐OrtegoP , BravoMC , MaderoR , Perez‐RodriguezJ , et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research2013;73(1):95‐103. ">Pellicer 2013</a>), which found no incidence. </p> <p>i) Left ventricular ejection fraction &lt; 50% or left ventricular fraction of shortening &lt; 28%: While echocardiographic measurements are not reported in two trials (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>; <a href="./references#CD009515-bbs2-0006" title="MomeniM , RubayJ , MattaA , RennotteMT , VeyckemansF , PonceletAJ , et al. Levosimendan in congenital cardiac surgery: a randomized, double‐blind clinical trial. Journal of Cardiothoracic and Vascular Anesthesia2011;25(3):419‐24. ">Momeni 2011</a>), one trial reports reduced echocardiographic left ventricular shortening fraction &lt; 28% as one of two possible reasons (besides hypotension) for administration of at least one catecholamine on the decision of the senior consultant, which was the case in 14/20 patients from the milrinone group and 14/20 patients from the levosimendan group (<a href="./references#CD009515-bbs2-0005" title="LechnerE , HoferA , Leitner‐PenederG , FreynschlagR , MairR , WeinzettelR , et al. Levosimendan versus milrinone in neonates and infants after corrective open‐heart surgery: a pilot study. Pediatric Critical Care Medicine2012;13(5):542‐8. ">Lechner 2012</a>; page 545). LVFS values are shown in a figure (<a href="./references#CD009515-bbs2-0005" title="LechnerE , HoferA , Leitner‐PenederG , FreynschlagR , MairR , WeinzettelR , et al. Levosimendan versus milrinone in neonates and infants after corrective open‐heart surgery: a pilot study. Pediatric Critical Care Medicine2012;13(5):542‐8. ">Lechner 2012</a>; figure 4, page 547), with values at two hours postoperatively of mean/SEM 31%/1.5% (milrinone group) and 34%/2% (comparison group), at 24 hours postoperatively of mean/SEM 35%/1.5% (milrinone group) and 34%/2% (comparison group), and at 48 hours postoperatively of mean/SEM 35%/2% (milrinone group) and not shown for the comparison group. However, it is not possible to determine the numbers of patients with LVFS &lt; 28% from these data. One other levosimendan trial (<a href="./references#CD009515-bbs2-0007" title="PellicerA , RieraJ , Lopez‐OrtegoP , BravoMC , MaderoR , Perez‐RodriguezJ , et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research2013;73(1):95‐103. ">Pellicer 2013</a>) reports the following numbers of patients with LVFS &lt; 28%: At baseline: none in either group. At 24 hours: milrinone group three of nine patients (33.3%); comparison group three of 11 patients (27.3%). At 48 hours: milrinone group one of seven patients (14.3%); comparison group one of six patients (16.7%). The milrinone versus dobutamine trial (<a href="./references#CD009515-bbs2-0001" title="Cavigelli‐BrunnerA , HugMI , DaveH , CannizzaroV , BaenzigerO , BuerkiC , et al. Therapy of low cardiac output syndrome after cardiac surgery in infants and children: a double blind randomized study comparing dobutamine and milrinone. Cardiology in the Young. May 2013; Vol. 23, Supplement S1:S34; O11‐3. ">Cavigelli 2013</a>) reports three time periods as well: a) two to six hours postoperatively: intervention five of 24 patients (20.8%) (LVFS values 16%; 27%, 13%, 25%, 25%); comparison 10 of 26 patients (38.5%) (LVFS values 26%; 13%; 25%; 23%; 24%; 9%; 26%; 25%; 24%; 16%). b) 24 to30 hours postoperatively: intervention six of 24 patients (25%); comparison five of 26 patients (19.2%). c) 48 to 54 hours postoperatively: intervention five of 24 patients (20.8%); comparison six of 26 patients (23.1%). </p> <p>This leaves one trial comparing milrinone with levosimendan (<a href="./references#CD009515-bbs2-0007" title="PellicerA , RieraJ , Lopez‐OrtegoP , BravoMC , MaderoR , Perez‐RodriguezJ , et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research2013;73(1):95‐103. ">Pellicer 2013</a>) and one trial comparing milrinone with dobutamine (<a href="./references#CD009515-bbs2-0001" title="Cavigelli‐BrunnerA , HugMI , DaveH , CannizzaroV , BaenzigerO , BuerkiC , et al. Therapy of low cardiac output syndrome after cardiac surgery in infants and children: a double blind randomized study comparing dobutamine and milrinone. Cardiology in the Young. May 2013; Vol. 23, Supplement S1:S34; O11‐3. ">Cavigelli 2013</a>), of which the incidences of LVFS &lt; 28% could be compared at time points of at least two hours, at least 24 hours, and at least 48 hours postoperatively. Due to the different types of comparison interventions however, we refrained from doing this. </p> <p>In addition to these adverse events we expected to analyse, the milrinone versus placebo trial (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>) generated some information about other possible side effects of milrinone (<a href="./references#CD009515-bbs2-0048" title="Medicines and Healthcare Products Regulatory Agency (UK), Paediatric Working Party ‐ Committee on Safety of Medicines. Review of paediatric data ‐ Primacor Injection. http://www.mhra.gov.uk/home/groups/pl‐p/documents/websiteresources/con2030490.pdf 2005, Apr 27; Vol. Accessed 2014, Sep 11. ">MHRA 2005</a>). These were fever (placebo 14/81 (17.3%), low‐dose milrinone 12/80 (15%), high‐dose milrinone 10/77 (13%), resulting in no significant difference between the groups receiving milrinone and the placebo group, with a risk ratio of 0.81 (95% CI 0.44 to 1.50) and stridor (placebo 10/81 (12.3%), LD 10/80 (12.5%), HD 10/77 (13%), not meeting statistical significance either with a risk ratio of 1.03 (95% CI 0.51 to 2.10). In addition, incidences of pleural effusion were reported, with a risk ratio of 1.78 for the groups receiving milrinone as compared to placebo, where the 95% CI of the RR marginally includes 1 (RR 1.78, 95% CI 0.92 to 3.42; 231 participants). Thus, statistical significance is not formally established (<a href="./references#CD009515-fig-0014" title="">Analysis 9.1</a>) (<a href="./references#CD009515-bbs2-0002" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman (HD vs. placebo)</a>; (<a href="./references#CD009515-bbs2-0003" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman (LD vs. placebo)</a>. </p> <p>No subgroups (age or physiology) were analysed within the patient population for the following reasons. Information about age or physiology was limited. In the studies using levosimendan as a comparative intervention, there were only very few patients older than one year. The number of patients with univentricular physiology was low (four out of 50 participants in <a href="./references#CD009515-bbs2-0001" title="Cavigelli‐BrunnerA , HugMI , DaveH , CannizzaroV , BaenzigerO , BuerkiC , et al. Therapy of low cardiac output syndrome after cardiac surgery in infants and children: a double blind randomized study comparing dobutamine and milrinone. Cardiology in the Young. May 2013; Vol. 23, Supplement S1:S34; O11‐3. ">Cavigelli 2013</a>), or none were included for participation at all. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009515-sec-0062" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009515-sec-0062">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009515-sec-0104">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009515-sec-0062"></div> <section id="CD009515-sec-0063"> <h3 class="title" id="CD009515-sec-0063">Summary of main results</h3> <p>Our search for studies of prophylactic postoperative milrinone in children undergoing corrective surgery for congenital heart defects yielded records from five studies meeting the inclusion criteria. The five studies were heterogeneous in terms of population numbers, interventions (inodilators used), and which outcomes they reported. In addition, milrinone was used in different dosages, with only two studies reporting pharmacokinetic data of their study participants (<a href="./references#CD009515-bbs2-0007" title="PellicerA , RieraJ , Lopez‐OrtegoP , BravoMC , MaderoR , Perez‐RodriguezJ , et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research2013;73(1):95‐103. ">Pellicer 2013</a> and <a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>: see <a href="./references#CD009515-bbs2-0008" title="BaileyJM , HoffmanTM , WesselDL , NelsonDP , AtzAM , ChangAC , et al. A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. Journal of Pharmacokinetics and Pharmacodynamics2004;31(1):43‐59. ">Bailey 2004</a>). </p> <p>Our question of whether milrinone prevents low cardiac output syndrome (LCOS) and mortality in children undergoing heart surgery for congenital heart disease remains largely unanswered. While patients treated with milrinone showed a lower relative risk for LCOS than those treated with placebo, this could be shown only for the first 36 hours postoperatively and only in the high‐dose arm of the trial comparing milrinone with placebo (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>). There was no statistically significant LCOS risk reduction in patients treated prophylactically with milrinone versus levosimendan. If used prophylactically, milrinone resulted in an absolute risk reduction for developing LCOS within 36 hours of congenital cardiac surgery of 14.2% (high‐dose arm of the <a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a> study versus placebo arm), resulting in a number needed to treat of eight in order to prevent one case of LCOS within this time frame. </p> <p>Mortality data were available from the three trials comparing milrinone and levosimendan, albeit with different durations of follow‐up, and no difference between both treatment groups was found. In studies of as small a size as the included studies, mortality differences are of course not to be expected. </p> <p>Secondary outcomes such as duration of intensive care unit (ICU) stay, hospital stay, mechanical ventilation, or maximum inotrope score were also not statistically different between the milrinone and the comparison groups. </p> <p>Safety outcomes or harms were reported so inconsistently that no comparisons between studies could be made. As far as arrhythmias are concerned, the prophylactic use of milrinone might increase patients' risk compared to placebo, according to <a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>, although the confidence interval was too wide to exclude no difference in arrhythmias between milrinone and placebo. </p> </section> <section id="CD009515-sec-0064"> <h3 class="title" id="CD009515-sec-0064">Overall completeness and applicability of evidence</h3> <p>There is insufficient evidence to judge the effect of milrinone on the studied population related to the primary outcomes of this review (30‐day mortality, time to death, or LCOS in the entire postoperative period) since follow‐up periods for mortality were variable between studies, and LCOS was not uniformly used as a defined outcome. </p> <p>Another difficulty is encountered when comparing studies that use placebo as a comparison intervention with studies that compare different inodilator drugs, such as milrinone versus levosimendan or milrinone versus dobutamine. Not all of these comparison interventions can reasonably be combined to one "comparison group" for the purposes of a meta‐analysis. </p> </section> <section id="CD009515-sec-0065"> <h3 class="title" id="CD009515-sec-0065">Quality of the evidence</h3> <p>Unfortunately but inherently to the situation, patient numbers of all five studies were low. No treatment arm in any single trial comprised more than 80 patients. </p> <p>Of note, while the earliest study (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>) compared milrinone with placebo, more recent pilot studies use milrinone as their comparison medication (which is now widely used in children after congenital heart surgery) in order to investigate a newer drug, levosimendan. The hypotheses of the respective studies that milrinone might prove better than placebo (except for short‐term reduction of LCOS), and possibly levosimendan better than milrinone, are not statistically supportable, according to our data. A robust conclusion regarding the objectives of the review can not be drawn based on the evidence available. </p> <p>Risk of bias was low in most instances in the included studies, and if there were incomplete descriptions in the published articles, additional information from the study authors led mostly to assessment as low risk of bias in the respective area. Blinding of participants and personnel (performance bias) and blinding of outcome assessment (detection bias) were deemed satisfactory in all included studies. Risk of allocation concealment bias (selection bias) and random sequence generation bias (selection bias) were low in all studies except <a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a> and the latter in <a href="./references#CD009515-bbs2-0001" title="Cavigelli‐BrunnerA , HugMI , DaveH , CannizzaroV , BaenzigerO , BuerkiC , et al. Therapy of low cardiac output syndrome after cardiac surgery in infants and children: a double blind randomized study comparing dobutamine and milrinone. Cardiology in the Young. May 2013; Vol. 23, Supplement S1:S34; O11‐3. ">Cavigelli 2013</a>. There was also concern about possible incomplete outcome data (attrition bias) and selective reporting (reporting bias) in the largest study (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>), as well as concern about other bias in terms of support of the study by a grant from the manufacturer (Sanofi Synthelabo) and co‐authorship of the study publication by manufacturer representatives (see 'Risk of bias' tables <a href="#CD009515-fig-0002">Figure 2</a> and <a href="#CD009515-fig-0003">Figure 3</a>). </p> </section> <section id="CD009515-sec-0066"> <h3 class="title" id="CD009515-sec-0066">Potential biases in the review process</h3> <p>The identification of relevant studies comprised updated electronic literature searches 11 months, 24 months, and 31 months after the original search, which were successful in identifying additional relevant studies. </p> <p>In order to obtain more information beyond which was reported in the literature and to complement incomplete outcome data, we contacted the authors of all included studies. All of them responded. However, some of the outcomes sought after for this review were not available, either due to the long time elapsed since the study had been conducted (<a href="./references#CD009515-bbs2-0004" title="HoffmanTM , WernovskyG , AtzAM , BaileyJM , AkbaryA , KocsisJF , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal2002;143(1):15‐21. HoffmanTM , WernovskyG , AtzAM , KulikTJ , NelsonDP , ChangAC , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation2003;107(7):996‐1002. ">Hoffman 2003</a>), or to a smaller number of outcomes in the study protocols than in the protocol of this review (<a href="./references#CD009515-bbs2-0001" title="Cavigelli‐BrunnerA , HugMI , DaveH , CannizzaroV , BaenzigerO , BuerkiC , et al. Therapy of low cardiac output syndrome after cardiac surgery in infants and children: a double blind randomized study comparing dobutamine and milrinone. Cardiology in the Young. May 2013; Vol. 23, Supplement S1:S34; O11‐3. ">Cavigelli 2013</a>; <a href="./references#CD009515-bbs2-0005" title="LechnerE , HoferA , Leitner‐PenederG , FreynschlagR , MairR , WeinzettelR , et al. Levosimendan versus milrinone in neonates and infants after corrective open‐heart surgery: a pilot study. Pediatric Critical Care Medicine2012;13(5):542‐8. ">Lechner 2012</a>; <a href="./references#CD009515-bbs2-0006" title="MomeniM , RubayJ , MattaA , RennotteMT , VeyckemansF , PonceletAJ , et al. Levosimendan in congenital cardiac surgery: a randomized, double‐blind clinical trial. Journal of Cardiothoracic and Vascular Anesthesia2011;25(3):419‐24. ">Momeni 2011</a>; <a href="./references#CD009515-bbs2-0007" title="PellicerA , RieraJ , Lopez‐OrtegoP , BravoMC , MaderoR , Perez‐RodriguezJ , et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research2013;73(1):95‐103. ">Pellicer 2013</a>;). </p> </section> <section id="CD009515-sec-0067"> <h3 class="title" id="CD009515-sec-0067">Agreements and disagreements with other studies or reviews</h3> <p>We know of no other studies dealing with our review question that would not have been examined for inclusion or included in this review. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009515-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/urn:x-wiley:14651858:media:CD009515:CD009515-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_t/tCD009515-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD009515-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/full#CD009515-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009515-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/urn:x-wiley:14651858:media:CD009515:CD009515-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_t/tCD009515-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009515-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/full#CD009515-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009515-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/urn:x-wiley:14651858:media:CD009515:CD009515-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_t/tCD009515-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009515-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/full#CD009515-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009515-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/urn:x-wiley:14651858:media:CD009515:CD009515-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_t/tCD009515-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Mortality, outcome: 1.1 Mortality milrinone versus levosimendan, Constant Continuity Correction.event.e = event in experimental group; n.e. = non‐event in experimental group; incr.e. = increment experimental group.event.c = event in control group; n.c. = non‐event in control group; incr.c. = increment control group." data-id="CD009515-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Mortality, outcome: 1.1 Mortality milrinone versus levosimendan, Constant Continuity Correction. </p> <p>event.e = event in experimental group; n.e. = non‐event in experimental group; incr.e. = increment experimental group. </p> <p>event.c = event in control group; n.c. = non‐event in control group; incr.c. = increment control group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/full#CD009515-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009515-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/urn:x-wiley:14651858:media:CD009515:CD009515-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_t/tCD009515-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Mortality, outcome: 1.1 Mortality milrinone versus levosimendan, Treatment Arm Continuity Correction.event.e = event in experimental group; n.e. = non‐event in experimental group; incr.e. = increment experimental group.event.c = event in control group; n.c. = non‐event in control group; incr.c. = increment control group." data-id="CD009515-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Mortality, outcome: 1.1 Mortality milrinone versus levosimendan, Treatment Arm Continuity Correction. </p> <p>event.e = event in experimental group; n.e. = non‐event in experimental group; incr.e. = increment experimental group. </p> <p>event.c = event in control group; n.c. = non‐event in control group; incr.c. = increment control group. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/full#CD009515-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009515-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/urn:x-wiley:14651858:media:CD009515:CD009515-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_t/tCD009515-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Mortality, Outcome 1 Mortality milrinone versus levosimendan." data-id="CD009515-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Mortality, Outcome 1 Mortality milrinone versus levosimendan.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#CD009515-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009515-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/urn:x-wiley:14651858:media:CD009515:CD009515-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_t/tCD009515-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 LCOS, Outcome 1 LCOS." data-id="CD009515-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 LCOS, Outcome 1 LCOS.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#CD009515-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009515-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/urn:x-wiley:14651858:media:CD009515:CD009515-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_t/tCD009515-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Intensive Care Unit stay, Outcome 1 Duration of ICU stay." data-id="CD009515-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Intensive Care Unit stay, Outcome 1 Duration of ICU stay.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#CD009515-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009515-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/urn:x-wiley:14651858:media:CD009515:CD009515-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_t/tCD009515-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Hospital stay, Outcome 1 Duration of hospital stay." data-id="CD009515-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Hospital stay, Outcome 1 Duration of hospital stay.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#CD009515-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009515-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/urn:x-wiley:14651858:media:CD009515:CD009515-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_t/tCD009515-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Mechanical ventilation, Outcome 1 Duration of mechanical ventilation." data-id="CD009515-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Mechanical ventilation, Outcome 1 Duration of mechanical ventilation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#CD009515-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009515-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/urn:x-wiley:14651858:media:CD009515:CD009515-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_t/tCD009515-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Inotrope score, Outcome 1 Maximum inotrope score." data-id="CD009515-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Inotrope score, Outcome 1 Maximum inotrope score.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#CD009515-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009515-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/urn:x-wiley:14651858:media:CD009515:CD009515-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_t/tCD009515-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Arrhythmia, Outcome 1 Arrhythmia." data-id="CD009515-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Arrhythmia, Outcome 1 Arrhythmia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#CD009515-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009515-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/urn:x-wiley:14651858:media:CD009515:CD009515-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_t/tCD009515-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Thrombocytopenia, Outcome 1 Thrombocytopenia." data-id="CD009515-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Thrombocytopenia, Outcome 1 Thrombocytopenia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#CD009515-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009515-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/urn:x-wiley:14651858:media:CD009515:CD009515-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_t/tCD009515-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Pleural effusion, Outcome 1 Pleural effusion." data-id="CD009515-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Pleural effusion, Outcome 1 Pleural effusion.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#CD009515-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/media/CDSR/CD009515/image_n/nCD009515-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD009515-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Data extraction form</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Questions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Answers</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AUTHORS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PUBLICATION ID</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PUBLICATION SOURCE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>STUDY DESIGN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DATES OF STUDY</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LOCATION</p> <p>and number of centres</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SETTING</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SEQUENCE GENERATION</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ALLOCATION SEQUENCE CONCEALMENT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>BLINDING</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OTHER CONCERNS ABOUT BIAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PARTICIPANTS</p> <p>Number screened</p> <p>Number randomised</p> <p>Number completed</p> <p>Number of male/female participants</p> <p>Participant ages</p> <p>Inclusion criteria</p> <p>Exclusion criteria</p> <p>Co‐morbidity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>INTERVENTIONS</p> <p>Total number of intervention groups</p> <p>Number of patients in each group</p> <p>Specific interventions: drugs</p> <p>Intervention details (bolus and infusion or infusion only, infusion rate, starting time of infusion after surgery, duration of infusion) </p> <p>Co‐interventions</p> <p>Follow‐up period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OUTCOMES</p> <p>Outcomes reported</p> <p>Subgroup analyses (infants/children, univentricular/biventricular)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RESULTS</p> <p>MORTALITY WITHIN 30 DAYS</p> <p>Sample size</p> <p>Number of missing participants</p> <p>Summary data for each intervention group</p> <p>Estimate of effect with confidence interval; P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TIME TO DEATH (CENSORED AFTER 3 MONTHS)</p> <p>Sample size</p> <p>Number of missing participants</p> <p>Summary data for each intervention group</p> <p>Estimate of effect with confidence interval; P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LCOS WITHIN 30 DAYS FROM SURGERY</p> <p>Sample size</p> <p>Number of missing participants</p> <p>LCOS definition (with diagnostic criteria)</p> <p>Summary data for each intervention group</p> <p>Estimate of effect with confidence interval; P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DURATION OF ICU STAY</p> <p>Sample size</p> <p>Number of missing participants</p> <p>Summary data for each intervention group</p> <p>Estimate of effect with confidence interval; P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DURATION OF HOSPITAL STAY</p> <p>Sample size</p> <p>Number of missing participants</p> <p>Summary data for each intervention group</p> <p>Estimate of effect with confidence interval; P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DURATION OF MECHANICAL VENTILATION</p> <p>Sample size</p> <p>Number of missing participants</p> <p>Summary data for each intervention group</p> <p>Estimate of effect with confidence interval; P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MAXIMUM INOTROPE SCORE</p> <p>Sample size</p> <p>Number of missing participants</p> <p>Summary data for each intervention group</p> <p>Estimate of effect with confidence interval; P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NUMBER OF PATIENTS REQUIRING MECHANICAL CIRCULATORY SUPPORT WITHIN 30 DAYS FROM SURGERY</p> <p>Sample size</p> <p>Number of missing participants</p> <p>Summary data for each intervention group</p> <p>Estimate of effect with confidence interval; P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NUMBER OF PATIENTS REQUIRING HEART TRANSPLANT WITHIN 30 DAYS FROM SURGERY</p> <p>Sample size</p> <p>Number of missing participants</p> <p>Summary data for each intervention group</p> <p>Estimate of effect with confidence interval; P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NUMBER/PROPORTION OF ADVERSE EVENTS</p> <p>arrhythmias</p> <p>tachycardia</p> <p>hypotension</p> <p>intraventricular haemorrhage</p> <p>hypokalaemia</p> <p>bronchospasm</p> <p>thrombocytopenia</p> <p>elevated serum levels of liver enzymes</p> <p>left ventricular ejection fraction &lt;50% or left ventricular fraction of shortening &lt; 28% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FUNDING SOURCE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>INTENTION‐TO‐TREAT ANALYSIS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>KEY CONCLUSIONS OF THE STUDY AUTHORS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MISCELLANEOUS COMMENTS FROM THE STUDY AUTHORS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>REFERENCES TO OTHER RELEVANT STUDIES</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CORRESPONDENCE REQUIRED?</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes/No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MISCELLANEOUS COMMENTS FROM THE REVIEW AUTHORS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RISK OF BIAS</p> <p>Random sequence generation</p> <p>Allocation concealment</p> <p>Blinding of participants and personnel</p> <p>Blinding of outcome assessment (Mortality)</p> <p>Blinding of outcome assessment (LCOS)</p> <p>Blinding of outcome assessment (Secondary outcomes)</p> <p>Blinding of outcome assessment (Safety outcomes)</p> <p>Incomplete outcome data (Mortality)</p> <p>Incomplete outcome data (LCOS)</p> <p>Incomplete outcome data (Secondary outcomes)</p> <p>Incomplete outcome data (Safety outcomes)</p> <p>Selective reporting</p> <p>Other sources of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> <p>High risk/ Low risk/Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CONSORT FLOW DIAGRAM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>ICU: intensive care unit<br/> LCOS: low cardiac output syndrome </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Data extraction form</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/full#CD009515-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009515-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Mortality</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality milrinone versus levosimendan <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.44 [0.26, 22.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Mortality</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#CD009515-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009515-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">LCOS</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 LCOS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.33, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Levosimendan</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.32, 4.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.28, 0.96]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">LCOS</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#CD009515-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009515-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Intensive Care Unit stay</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Duration of ICU stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐1.89, 1.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Levosimendan</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐4.36, 4.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Dobutamine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐0.71, 1.31]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Intensive Care Unit stay</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#CD009515-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009515-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Hospital stay</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Duration of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [‐2.75, 4.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Levosimendan</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.26 [‐4.03, 3.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Dobutamine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.20 [‐2.69, 15.09]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Hospital stay</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#CD009515-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009515-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Mechanical ventilation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Duration of mechanical ventilation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [1.00, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Levosimendan</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐2.47, 2.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Dobutamine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [‐0.04, 0.95]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Mechanical ventilation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#CD009515-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009515-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Inotrope score</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maximum inotrope score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.04 [‐9.08, 17.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Inotrope score</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#CD009515-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009515-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Arrhythmia</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Arrhythmia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>308</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.99 [0.88, 4.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Levosimendan</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.07, 5.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Dobutamine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.90 [0.63, 5.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.59 [0.83, 15.42]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Arrhythmia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#CD009515-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009515-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Thrombocytopenia</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Thrombocytopenia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.39, 1.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Thrombocytopenia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#CD009515-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009515-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Pleural effusion</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pleural effusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.78 [0.92, 3.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Pleural effusion</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009515.pub2/references#CD009515-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009515.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009515-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009515-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009515-note-0001">Français</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009515\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009515\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009515\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009515\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009515\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009515\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009515\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009515\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009515\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009515\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009515\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009515\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009515\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009515\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009515\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009515\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009515\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009515\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=wbKFI7vu&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009515.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009515.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009515.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009515.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009515.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719470452"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009515.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719470456"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009515.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918de97c8c55f55b',t:'MTc0MDcxOTQ3MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 